Atlanticus to Host First Quarter 2026 Earnings Call and Webcast on May 7, 2026 at 5:00 p.m. ET

ATLANTA, April 30, 2026 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that it will host a conference call and live webcast to discuss its first quarter financial results and operating performance on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time.

The live webcast will be accessible at the Atlanticus Investor Relations website at https://investors.atlanticus.com/news-market-information/event-calendar, along with the Company’s first quarter earnings press release and first quarter investor presentation. An archived version of the webcast will be available on the Atlanticus Holdings Corporation Investor Relations website for 45 days.

About Atlanticus Holdings Corporation

Atlanticus Holdings Corporation empowers better financial outcomes for everyday Americans by enabling bank, retail, healthcare, and automotive partners to offer more inclusive financial solutions to consumers. Leveraging proprietary technology and advanced analytics, Atlanticus applies more than 30 years of operating experience, servicing over 20 million customers and more than $50 billion in consumer loans, to support lenders across a broad range of consumer credit products. For more information, visit www.atlanticus.com.

Contact:

Investor Relations, [email protected]
Dan Mauch, [email protected]
Sara Savarino, [email protected]



Cerus Corporation Announces First Quarter 2026 Financial Results

Cerus Corporation Announces First Quarter 2026 Financial Results

First Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year

Raising Full Year Product Revenue Guidance Range to $227 million – $231 million, reflecting 10% to 12% year-over-year increase

CONCORD, Calif.–(BUSINESS WIRE)–
Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2026, and provided a business update.

“We delivered a strong start to 2026, with first quarter performance driven by strength across our business, in particular by increasing demand for our INTERCEPT Fibrinogen Complex,” said William “Obi” Greenman, Cerus’ president and chief executive officer. “As a result, we are raising our product revenue guidance for the year. Looking ahead, we have a meaningful catalyst path in 2026, spanning anticipated regulatory, clinical, and pipeline milestones, including ongoing INTERCEPT RBC regulatory review in Europe, the Phase 3 RedeS readout in the U.S., and the planned U.S. PMA submission for our new INT200 illumination device.”

Additional highlights include:

  • First quarter 2026 total revenue comprised of (in millions, except percentages):

 

Three Months Ended

 

 

 

 

 

 

 

March 31,

 

 

Change

 

2026

 

 

2025

 

 

$

 

 

%

Product Revenue

$

53.7

 

 

$

43.2

 

 

$

10.4

 

 

 

24%

Government Contract Revenue

 

6.2

 

 

 

5.6

 

 

 

0.6

 

 

 

11%

Total Revenue

$

59.9

 

 

$

48.9

 

 

$

11.0

 

 

 

23%

Numbers may not sum due to rounding. Percentages calculated from unrounded figures.

  • INTERCEPT Fibrinogen Complex (IFC) demand continued to increase, with first quarter volumes – including kits and finished therapeutic doses (measured in FC15* equivalent units) – up approximately 120% compared to the prior year period. First quarter U.S. IFC sales totaled $5.7 million, up from $3.0 million in the prior year period.

  • Signed a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System for platelets and plasma, as well as the INT200.

  • Announced Vivek Jayaraman, Cerus’ chief operating officer, will be appointed as president and chief executive officer and as a member of the board of directors, effective July 1, 2026. William “Obi” Greenman will become executive chairman of the board of directors.

  • Cash, cash equivalents, and short-term investments were $80.4 million at March 31, 2026.

Revenue

Product revenue for the first quarter of 2026 was $53.7 million, compared to $43.2 million for the prior year period, representing year-over-year growth of 24%. First quarter growth was primarily driven by the strength of the global platelet franchise as well as increased U.S. IFC sales.

Government contract revenue for the first quarter of 2026 was $6.2 million, compared to $5.6 million during the prior year period. The increase was driven by higher BARDA and Department of Defense related projects offset by the completion of the FDA contract in 2025.

Product Gross Profit & Margin

Product gross profit for the first quarter of 2026 was $27.9 million, compared to $25.4 million, increasing by 10% over the prior year period. Product gross margin for the first quarter of 2026 was 52.0% compared to 58.8% in the same period last year. The year-over-year decrease in gross margin was driven by the favorable prior year impact of a one-time benefit related to the capitalization of inventoriable charges and current period inflationary pressures, unfavorable foreign currency, and tariff impacts.

Operating Expenses

Total operating expenses for the first quarter of 2026 were $34.5 million, compared to $36.9 million for the same period of the prior year, reflecting a year-over-year decline of 7%.

Research and development expenses for the first quarter of 2026 were $14.5 million, compared to $16.6 million for the same period of the prior year, reflecting a 12% decrease. The decrease was primarily driven by lower development costs of INT200 as we approach the planned PMA submission in the U.S. Government funded R&D spending, as a percentage of total R&D expense, increased year-over-year as seen with the higher government contract revenue.

Selling, general and administrative expenses for the first quarter of 2026 totaled $19.9 million, compared to $20.3 million for the same period of the prior year, reflecting a 2% decrease and largely consistent with prior year costs, reflecting our ongoing focus on driving leverage.

Net Loss Attributable to Cerus Corporation

Net loss attributable to Cerus Corporation for the first quarter of 2026 was $1.6 million, or $0.01 per basic and diluted share, compared to a net loss attributable to Cerus Corporation of $7.7 million, or $0.04 per basic and diluted share, for the same period of the prior year.

Non-GAAP Adjusted EBITDA

Non-GAAP adjusted EBITDA for the first quarter of 2026 was $4.0 million, compared to non-GAAP adjusted EBITDA of $0.2 million for the same period of the prior year. For additional information, please see definitions and the reconciliation of this non-GAAP measure to net loss attributable to Cerus Corporation accompanying this release.

Balance Sheet and Cash Flows

At March 31, 2026, the Company had cash, cash equivalents, and short-term investments of $80.4 million, compared to $82.9 million at December 31, 2025.

As of March 31, 2026, the Company had $65.0 million outstanding on its term loan and $19.9 million drawn on its revolving credit facility. The Company’s revolving line of credit allows for an additional $15.1 million as of March 31, 2026, which is dependent on eligible assets supporting the borrowing base.

For the first quarter of 2026, cash used for operations totaled $3.0 million compared to $0.8 million during the same period of the prior year. Cash used for operations in the first quarter of 2026 was primarily tied to an increase in working capital, including inventory in support of the expected product revenue growth.

Raising 2026 Product Revenue Guidance

The Company now expects full-year 2026 product revenue to be in the range of $227 million to $231 million, reflecting growth of 10% to 12% from 2025. Included in this range is full-year 2026 IFC revenue guidance between $22 million to $24 million. Previously, the Company’s 2026 product revenue guidance range was $224 million to $228 million, including IFC revenue guidance between $20 million to $22 million.

Quarterly Conference Call

The Company will host a conference call at 4:30 P.M. ET this afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook. To listen to the live webcast, please visit the Investor Relations page of the Cerus website at http://www.cerus.com/ir.

A replay will be available on Cerus’ website approximately three hours after the call through May 21, 2026.

*FC15 equivalent to a therapeutic dose of a cryoAHF pool.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the U.S. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

Forward-Looking Statements

Except for the historical statements contained herein, this press release contains forward-looking statements concerning Cerus’ products, prospects and expected results, including statements relating to: Cerus’ expectation that full-year 2026 product revenue will be in the range of $227 million to $231 million, including IFC revenue of between $22 million to $24 million; Cerus’ expectation that full-year 2026 product revenue will grow 10% to 12% year over year; Cerus continuing to have access to $15.1 million under its revolving line of credit; Cerus’ anticipated catalyst path in 2026, including ongoing INTERCEPT RBC regulatory review in Europe, the Phase 3 RedeS readout in the U.S., and the planned U.S. PMA submission for Cerus’ new INT200 illumination device; Cerus’ expectations with respect to its new four-year supply agreement with EFS; Cerus’ expectations regarding the transition of the President and Chief Executive Officer role; Cerus’ ability to continue to improve global access to its INTERCEPT technologies; Cerus’ ability to advance its product development programs; the continued commercialization and launch of INT200 and IFC; and other statements that are not historical fact. Actual results could differ materially from these forward-looking statements as a result of certain factors, including, without limitation: risks associated with the commercialization and market acceptance of, and customer demand for, the INTERCEPT Blood System and IFC; the risk that Cerus may not meet its 2026 annual product revenue guidance; the risk that Cerus may not effectively continue to launch and commercialize the INTERCEPT Blood System for Cryoprecipitation or INT200; the risk that Cerus may not grow sales globally, including in its U.S. and European markets, and/or realize expected revenue contributions resulting from its U.S. and European market agreements; the risk that the U.S. RedeS study may take longer than Cerus expects or may not be completed at all or, if completed, may not demonstrate the safety and/or efficacy of the red blood cell system; risks related to the uncertain and time-consuming development and regulatory process, including the risk that Cerus may be unable to obtain requisite regulatory approvals to advance its pipeline programs and bring them to market in a timely manner or at all, including the risks that existing clinical data may be insufficient in order to obtain a CE Certificate of Conformity and affix a CE Mark to the red blood cell system and its planned modular premarket approval, or PMA, application for the red blood cell system and/or the INT200 may not be submitted to the FDA on the timeline Cerus anticipates or at all; risks associated with macroeconomic developments, including the ongoing military conflict in Ukraine and the ongoing military conflict involving Iran, the U.S. and Israel, new or increased tariffs and escalating trade tensions, inflation, rising interest rates and foreign exchange volatility and the resulting global economic and financial disruptions; risks related to Cerus’ ability to demonstrate to the transfusion medicine community and other healthcare constituencies that pathogen reduction and the INTERCEPT Blood System are safe, effective and economical; risks related to product safety; risks associated with Cerus’ ability to maintain an effective, secure manufacturing supply chain, including risks that (a) Cerus’ supply chain could be negatively impacted as a result of macroeconomic developments, (b) Cerus’ manufacturers could be unable to comply with extensive regulatory agency requirements, and (c) Cerus may be unable to maintain its supply agreements with its third-party suppliers; risks associated with Cerus’ ability to access additional funds under its credit facility and to meet its debt service obligations, and its need for additional funding; risks associated with the impact of legislative or regulatory healthcare reforms that may make it more difficult and costly for Cerus to produce, market and distribute its products; as well as other risks detailed in Cerus’ filings with the Securities and Exchange Commission, including under the heading “Risk Factors” in Cerus’ Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 2, 2026 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Cerus disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release.

Use of Non-GAAP Financial Measures

We define adjusted EBITDA as net loss attributable to Cerus Corporation as reported on the consolidated statement of operations, as adjusted to exclude, as applicable for the reporting period(s) presented, (i) net loss attributable to noncontrolling interest, (ii) provision for income taxes, (iii) foreign exchange (loss)/gain, (iv) interest income (expense), (v) other income (expense), net, (vi) depreciation and amortization, (vii) share-based compensation, (viii) goodwill and asset impairments, (ix) costs associated with our noncontrolling interest in our joint venture in China and, (x) revenue and direct costs associated with our government contracts. We are presenting this non-GAAP financial measure to assist investors in assessing our operating results. Management believes this non-GAAP information is useful for investors, when considered in conjunction with Cerus’ GAAP financial statements, because management uses such information internally for its operating, budgeting and financial planning purposes. Non-GAAP information is not prepared under a comprehensive set of accounting rules and should only be used to supplement an understanding of Cerus’ operating results as reported under GAAP. This non-GAAP financial measure should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. This non-GAAP financial measure is not necessarily comparable to similarly-titled measures presented by other companies.

Supplemental Tables

 

Three Months Ended

 

March 31,

 

2026 vs. 2025

Platelet Kit Growth

 

North America

6%

International

25%

Worldwide

10%

 

 

Change in Calculated Number of Treatable Platelet Doses

North America

9%

International

26%

Worldwide

13%

Dose treatable calculation based on the number of kits sold and the product configuration (single, double, and triple dose kits)

 

Three Months Ended

March 31,

2026 vs. 2025

Total IFC* Demand Growth

(including kits and finished therapeutic doses)

~120%

*FC15 equivalent to a therapeutic dose of a cryoAHF pool.

 

 

CERUS CORPORATION

 

REVENUE BY REGION

 

(in thousands, except percentages)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

March 31,

 

 

Change

 

 

2026

 

 

2025

 

 

$

 

 

%

 

North America

$

36,756

 

 

$

30,601

 

 

$

6,155

 

 

 

20

%

Europe, Middle East and Africa

 

15,679

 

 

 

12,211

 

 

 

3,468

 

 

 

28

%

Other

 

1,226

 

 

 

427

 

 

 

799

 

 

 

187

%

Total product revenue

$

53,661

 

 

$

43,239

 

 

$

10,422

 

 

 

24

%

 

CERUS CORPORATION

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

UNAUDITED

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2026

 

 

2025

 

Product revenue

 

$

53,661

 

 

$

43,239

 

Cost of product revenue

 

 

25,767

 

 

 

17,815

 

Gross profit on product revenue

 

 

27,894

 

 

 

25,424

 

Government contract revenue

 

 

6,232

 

 

 

5,614

 

Operating expenses:

 

 

 

 

 

 

Research and development

 

 

14,532

 

 

 

16,605

 

Selling, general and administrative

 

 

19,948

 

 

 

20,286

 

Total operating expenses

 

 

34,480

 

 

 

36,891

 

Loss from operations

 

 

(354

)

 

 

(5,853

)

Total non-operating expense, net

 

 

(1,203

)

 

 

(1,791

)

Loss before income taxes

 

 

(1,557

)

 

 

(7,644

)

Provision for income taxes

 

 

91

 

 

 

74

 

Net loss

 

 

(1,648

)

 

 

(7,718

)

Net loss attributable to noncontrolling interest

 

 

(8

)

 

 

(1

)

Net loss attributable to Cerus Corporation

 

$

(1,640

)

 

$

(7,717

)

Net loss per share attributable to Cerus Corporation

 

 

 

 

 

 

Basic and diluted

 

$

(0.01

)

 

$

(0.04

)

Weighted average shares outstanding:

 

 

 

 

 

 

Basic and diluted

 

 

194,142

 

 

 

187,066

 

 

CERUS CORPORATION

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

March 31,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,850

 

 

$

19,961

 

Short-term investments

 

 

52,575

 

 

 

62,918

 

Accounts receivable, net

 

 

29,322

 

 

 

30,374

 

Current inventories

 

 

61,123

 

 

 

56,101

 

Prepaid and other current assets

 

 

4,471

 

 

 

5,030

 

Total current assets

 

 

175,341

 

 

 

174,384

 

Non-current assets:

 

 

 

 

 

 

Property and equipment, net

 

 

9,248

 

 

 

9,204

 

Operating lease right-of-use assets

 

 

9,450

 

 

 

10,124

 

Goodwill

 

 

1,316

 

 

 

1,316

 

Non-current inventories

 

 

15,723

 

 

 

15,143

 

Other assets and restricted cash

 

 

11,830

 

 

 

11,688

 

Total assets

 

$

222,908

 

 

$

221,859

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

50,121

 

 

$

53,279

 

Debt – current

 

 

52,397

 

 

 

43,343

 

Operating lease liabilities – current

 

 

3,144

 

 

 

2,905

 

Deferred revenue – current

 

 

1,721

 

 

 

1,274

 

Total current liabilities

 

 

107,383

 

 

 

100,801

 

Non-current liabilities:

 

 

 

 

 

 

Debt – non-current

 

 

32,434

 

 

 

40,545

 

Operating lease liabilities – non-current

 

 

9,383

 

 

 

10,153

 

Other non-current liabilities

 

 

5,422

 

 

 

5,395

 

Total liabilities

 

 

154,622

 

 

 

156,894

 

Stockholders’ equity:

 

 

67,553

 

 

 

64,224

 

Noncontrolling interest

 

 

733

 

 

 

741

 

Total liabilities and stockholders’ equity

 

$

222,908

 

 

$

221,859

 

CERUS CORPORATION

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTED EBITDA

(in thousands)

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31,

 

 

2026

 

 

2025

 

Net loss attributable to Cerus Corporation

$

(1,640

)

 

$

(7,717

)

 

 

 

 

 

 

Adjustments to net loss attributable to Cerus Corporation:

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to noncontrolling interest

 

(8

)

 

 

(1

)

Provision for income taxes

 

91

 

 

 

74

 

Total non-operating expense, net (i)

 

1,203

 

 

 

1,791

 

Loss from operations

 

(354

)

 

 

(5,853

)

 

 

 

 

 

 

Adjustments to loss from operations:

 

 

 

 

 

 

 

 

 

 

 

Operating depreciation and amortization

 

1,223

 

 

 

1,015

 

Government contract revenue (ii)

 

(6,232

)

 

 

(5,614

)

Direct expenses attributable to government contracts (iii)

 

4,449

 

 

 

3,971

 

Share-based compensation (iv)

 

4,904

 

 

 

6,635

 

Costs attributable to noncontrolling interest (v)

 

17

 

 

 

3

 

Non-GAAP adjusted EBITDA

$

4,007

 

 

$

157

 

 

 

 

 

 

 

 

 

 

 

 

 

i. Includes interest income/expense and foreign exchange gains/losses.

ii. Represents revenue related to the cost reimbursement provisions under our government contracts.

iii. Represents the direct expenses attributable to work supporting government contracts, which are reimbursed and reflect under government contract revenue in the condensed consolidated statement of operations.

iv. Represents non-cash stock-based compensation.

 

 

 

 

 

v. Represents costs associated with the noncontrolling interest in Cerus Zhongbaokang (Shandong) Biomedical Co., LTD.

 

Tim Lee – Head of Investor Relations

Cerus Corporation

[email protected]

925-288-6128

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: General Health Hospitals Health Health Technology Medical Supplies

MEDIA:

Logo
Logo

Arhaus to Announce First Quarter 2026 Financial Results on May 7, 2026

BOSTON HEIGHTS, Ohio, April 30, 2026 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, will release its first quarter 2026 results on Thursday, May 7, 2026, before the stock market opens, followed by a conference call to review the Company’s financial and operational results at 8:30 a.m. Eastern Time.

A live webcast will be available at ir.arhaus.com.

To participate in the live call, dial:

U.S. Toll-Free: (877) 407-3982
International: 1 (201) 493-6780
Conference ID: 13758506

A telephone replay will be available for one week at:

U.S. Toll-Free: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 13758506

A webcast replay will remain available at ir.arhaus.com for approximately 12 months.

About Arhaus

Founded in 1986 by Chief Executive Officer John Reed and his father, Arhaus is a premium home furnishings brand built on a simple idea: furniture and décor should be responsibly sourced, lovingly made, and built to last. Arhaus operates a vertically integrated model, designing and sourcing products directly from skilled artisans and carefully selected manufacturing partners around the world, including domestic upholstery production at its own North Carolina manufacturing facility. This approach enables Arhaus to offer a highly exclusive and customizable assortment of heirloom-quality furniture and décor designed to be used and enjoyed for generations.

With more than 100 Showroom locations across the United States, Arhaus’ integrated omni-channel model connects every client touchpoint, from Showroom and interior design to eCommerce and catalog, allowing Arhaus to meet clients wherever and however they choose to shop while delivering a highly personalized client-first experience from discovery through delivery.

For more information, please visit www.arhaus.com.

Investor Contact:

Tara Louise Atwood-Saja
Vice President, Investor Relations
(440) 439-7700
[email protected]



OneSpan Reports First Quarter 2026 Financial Results

OneSpan Reports First Quarter 2026 Financial Results

  • Revenue increased 4% year-over-year to $65.9 million
  • Subscription revenue increased 8% year-over-year to $52.7 million
  • Operating income decreased 14% year-over-year to $14.8 million
  • Adjusted EBITDA decreased 9% year-over-year to $21.0 million1
  • Annual Recurring Revenue (ARR) increased 14% year-over-year to $192.1 million2
  • Net Retention Rate (NRR) of 105%3

 

BOSTON–(BUSINESS WIRE)–
OneSpan Inc. (NASDAQ: OSPN) today reported financial results for the first quarter ended March 31, 2026.

“We delivered a strong first quarter with solid profitability and subscription revenue growth,” stated OneSpan CEO, Victor Limongelli. “We also closed the acquisition of Build38, which strengthens our cybersecurity product portfolio by enabling customers to build threat protection into their mobile applications, and by providing the telemetry necessary for visibility into the threat and operating environment. As we invest organically and through targeted M&A, we remain focused on driving efficient revenue growth, maintaining strong profitability and cash generation, and returning capital to shareholders.”

First Quarter 2026 Financial Highlights

  • Total revenue was $65.9 million, an increase of 4% compared to $63.4 million for the same quarter of 2025. Cybersecurity revenue was $48.5 million, an increase of 2% year-over-year. Digital Agreements revenue was $17.4 million, an increase of 11% year-over-year.
  • ARRincreased 14% year-over-year to $192.1 million.
  • Gross profit was $48.5 million, or 74% gross margin, compared to $47.1 million, or 74% gross margin, in the same period last year.
  • Operating income was $14.8 million, compared to operating income of $17.2 million in the same period last year.
  • Net income was $11.6 million, or $0.30 per diluted share, compared to net income of $14.5 million, or $0.37 per diluted share, in the same period last year. Non-GAAP net income was $14.8 million, or $0.39 per diluted share, compared to non-GAAP net income of $17.7 million, or $0.45 per diluted share in the same period last year.1
  • Adjusted EBITDA was $21.0 million, compared to $23.0 million in the same period last year.
  • Cash and cash equivalents were $49.8 million at March 31, 2026 compared to $70.5 million at December 31, 2025.
  • OneSpan repurchased approximately 510,000 shares of its common stock for $5.4 million.

Recent Business Highlights

  • OneSpan completed its acquisition of Build38, a provider of next-generation mobile application protection solutions, to expand its App Shielding capabilities and enable its customers to strengthen their mobile channels through continuous in-app protection, cloud-powered threat intelligence, and adaptive, AI-enabled defenses.

  • The Company’s Board of Directors has declared a quarterly cash dividend of $0.13 per share as part of the Company’s recurring quarterly dividend program. The dividend is payable on June 4, 2026 to shareholders of record as of the close of business on May 14, 2026.

  • OneSpan was named an Overall Leader, Product Leader, Innovation Leader, and Market Leader in the 2026 KuppingerCole Leadership Compass: Passwordless Authentication for Enterprises.

Financial Outlook

OneSpan is updating its previously issued financial guidance to reflect an increase in its ARR expectations. For the Full Year 2026, the Company expects:

  • Total revenue to be in the range of $244 million to $249 million.

  • Software and services revenue to be in the range of $201 million to $204 million.

  • Hardware revenue to be in the range of $43 million to $45 million.

  • ARR to be in the range of $194 million to $198 million, as compared to its previous guidance range of $192 million to $196 million.

  • Adjusted EBITDAto be in the range of $64 million to $68 million.

Conference Call Details

In conjunction with this announcement, OneSpan Inc. will host a conference call today, April 30, 2026, at 4:30 p.m. ET. During the conference call, Mr. Victor Limongelli, CEO, and Mr. Jorge Martell, CFO, will discuss OneSpan’s results for the first quarter 2026.

For investors and analysts accessing the conference call by phone, please refer to the press release dated April 9, 2026, announcing the date of OneSpan’s first quarter 2026 earnings release. It can be found on the OneSpan investor relations website at investors.onespan.com.

The conference call is also available in listen-only mode at investors.onespan.com. Shortly after the conclusion of the call, a replay of the webcast will be available on the same website for approximately one year.

  1. An explanation of the use of Non-GAAP financial measures is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of each Non-GAAP financial measure to the most directly comparable GAAP financial measure has also been provided in the tables below. We are not providing a reconciliation of Adjusted EBITDA guidance to GAAP net income, the most directly comparable GAAP measure, because we are unable to predict certain items included in GAAP net income without unreasonable efforts.

  2. ARR is calculated as the approximate annualized value of our customer recurring contracts as of the measurement date. These include subscription, term-based license, and maintenance and support contracts and exclude one-time fees. To the extent that we are negotiating a renewal with a customer within 90 days after the expiration of a recurring contract, we continue to include that revenue in ARR if we are actively in discussion with the customer for a new recurring contract or renewal and the customer has not notified us of an intention to not renew. See our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 for additional information describing how we define ARR, including how ARR differs from GAAP revenue.

  3. NRR is defined as the approximate year-over-year growth in ARR from the same set of customers at the end of the prior year period.

About OneSpan

OneSpan helps organizations build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity and Digital Agreements. Our cybersecurity solutions protect identities, secure mobile apps, and safeguard access through advanced high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks. Our digital agreement solutions streamline agreement workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and exceptional customer experiences. Trusted by leading global enterprises, including more than 60% of the world’s 100 largest banks, OneSpan processes over 100 million digital agreements and billions of secure authentication transactions across more than 120 countries each year.

For more information, visit our website, explore our blog, or follow us on LinkedIn or YouTube.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable U.S. securities laws, including statements regarding our 2026 financial guidance; our plans to drive efficient revenue growth, maintain strong profitability and cash generation, and return capital to shareholders; and our general goals and expectations regarding our operational or financial performance in the future. Forward-looking statements may be identified by words such as “seek”, “believe”, “plan”, “estimate”, “anticipate”, “expect”, “intend”, “continue”, “outlook”, “may”, “will”, “should”, “could”, or “might”, and other similar expressions. These forward-looking statements involve risks and uncertainties, as well as assumptions that, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Factors that could materially affect our business and financial results include, but are not limited to: our ability to attract new customers and retain and expand sales to existing customers; our ability to successfully develop and market new product offerings and product enhancements; changes in customer requirements; the potential effects of technological changes; the loss of one or more large customers; difficulties enhancing and maintaining our brand recognition; competition; lengthy sales cycles; unintended costs and consequences of our cost reduction and restructuring actions, including higher than anticipated restructuring charges, disruption to our operations, litigation or regulatory actions, or employee turnover; challenges retaining key employees and successfully hiring and training qualified new employees; security breaches or cyber-attacks; real or perceived malfunctions or errors in our products; interruptions or delays in the performance of our products and solutions; reliance on third parties for certain products and data center services; our ability to effectively manage third party partnerships, acquisitions, divestitures, alliances, or joint ventures; economic recession, inflation, tariffs or trade disputes, and political instability; claims that we have infringed the intellectual property rights of others; changing laws, government regulations or policies; pressures on price levels; component shortages; delays and disruption in global transportation and supply chains; impairment of goodwill or amortizable intangible assets causing a significant charge to earnings; actions of activist stockholders; and exposure to increased economic and operational uncertainties from operating a global business, as well as other factors described in the “Risk Factors” section of our most recent Annual Report on Form 10-K, as updated by the “Risk Factors” section of our subsequent Quarterly Reports on Form 10-Q (if any). Our filings with the Securities and Exchange Commission and other important information can be found in the Investor Relations section of our website at investors.onespan.com. We do not have any intent, and disclaim any obligation, to update the forward-looking information to reflect events that occur, circumstances that exist or changes in our expectations after the date of this press release, except as required by law.

Unless otherwise noted, references in this press release to “OneSpan”, “Company”, “we”, “our”, and “us” refer to OneSpan Inc. and its subsidiaries.

OneSpan Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

Three Months Ended

March 31,

 

2026

 

2025

Revenue

 

 

 

Product and license

$

35,507

 

 

$

37,240

 

Services and other

 

30,440

 

 

 

26,126

 

Total revenue

 

65,947

 

 

 

63,366

 

 

 

 

 

Cost of goods sold

 

 

 

Product and license

 

8,760

 

 

 

8,718

 

Services and other

 

8,673

 

 

 

7,557

 

Total cost of goods sold

 

17,433

 

 

 

16,275

 

 

 

 

 

Gross profit

 

48,514

 

 

 

47,091

 

 

 

 

 

Operating costs

 

 

 

Sales and marketing

 

12,679

 

 

 

11,457

 

Research and development

 

9,078

 

 

 

7,928

 

General and administrative

 

10,958

 

 

 

9,547

 

Amortization of intangible assets

 

698

 

 

 

556

 

Write-off of assets

 

284

 

 

 

 

Restructuring and other related charges

 

 

 

 

421

 

Total operating costs

 

33,697

 

 

 

29,909

 

 

 

 

Operating income

 

14,817

 

 

 

17,182

 

 

 

 

 

Interest (expense) income, net

 

(19

)

 

 

692

 

Other expense, net

 

(386

)

 

 

(9

)

 

 

 

 

Income before income taxes

 

14,412

 

 

 

17,865

 

Provision for income taxes

 

2,847

 

 

 

3,360

 

 

 

 

 

Net income

$

11,565

 

 

$

14,505

 

 

 

 

 

Net income per share

 

 

 

Basic

$

0.31

 

 

$

0.38

 

Diluted

$

0.30

 

 

$

0.37

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

Basic

 

37,611

 

 

 

38,106

 

Diluted

 

38,070

 

 

 

39,027

 

 

 

 

 

OneSpan Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, unaudited)

 

 

March 31,

 

December 31,

 

2026

 

2025

ASSETS

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

49,754

 

 

$

70,499

 

Accounts receivable, net of allowances of $1,204 at March 31, 2026 and $1,227 at December 31, 2025

 

33,245

 

 

 

55,999

 

Inventories, net

 

9,137

 

 

 

10,466

 

Prepaid expenses

 

7,147

 

 

 

7,044

 

Contract assets

 

13,543

 

 

 

18,269

 

Other current assets

 

10,057

 

 

 

9,936

 

Total current assets

 

122,883

 

 

 

172,213

 

Property and equipment, net

 

22,902

 

 

 

22,234

 

Operating lease right-of-use assets

 

7,147

 

 

 

7,356

 

Goodwill

 

128,144

 

 

 

103,840

 

Intangible assets, net of accumulated amortization

 

16,481

 

 

 

9,741

 

Deferred income taxes

 

59,069

 

 

 

54,733

 

Equity investment

 

11,834

 

 

 

11,834

 

Other assets

 

14,686

 

 

 

15,751

 

Total assets

$

383,146

 

 

$

397,702

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities

 

 

 

Accounts payable

$

11,122

 

 

$

13,726

 

Deferred revenue

 

60,732

 

 

 

71,641

 

Accrued wages and payroll taxes

 

11,970

 

 

 

13,553

 

Short-term income taxes payable

 

1,749

 

 

 

3,079

 

Dividend payable

 

671

 

 

 

671

 

Other accrued expenses

 

11,749

 

 

 

11,859

 

Deferred compensation

 

8

 

 

 

42

 

Total current liabilities

 

98,001

 

 

 

114,571

 

Long-term deferred revenue

 

2,395

 

 

 

2,539

 

Long-term lease liabilities

 

5,796

 

 

 

6,139

 

Deferred income taxes

 

989

 

 

 

988

 

Other long-term liabilities

 

3,949

 

 

 

1,622

 

Total liabilities

 

111,130

 

 

 

125,859

 

Commitments and contingencies

 

 

 

Stockholders’ equity

 

 

 

Preferred stock: 500 shares authorized, none issued and outstanding at March 31, 2025 and December 31, 2025

 

 

 

 

 

Common stock: $0.001 par value per share, 75,000 shares authorized; 42,220 and 42,091 shares issued; 36,982 and 37,361 shares outstanding at March 31, 2026 and December 31, 2025, respectively.

 

37

 

 

 

37

 

Additional paid-in capital

 

129,541

 

 

 

128,651

 

Treasury stock, at cost: 5,238 and 4,730 shares outstanding at March 31, 2026 and December 31, 2025, respectively

 

(65,922

)

 

 

(60,521

)

Retained earnings

 

216,423

 

 

 

209,821

 

Accumulated other comprehensive loss

 

(8,063

)

 

 

(6,145

)

Total stockholders’ equity

 

272,016

 

 

 

271,843

 

Total liabilities and stockholders’ equity

$

383,146

 

 

$

397,702

 

OneSpan Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

 

Three Months Ended March 31,

 

2026

 

2025

Cash flows from operating activities:

 

 

 

Net income

$

11,565

 

 

$

14,505

 

Adjustments to reconcile net income from operations to net cash provided by operations:

 

 

 

Depreciation and amortization of intangible assets

 

3,132

 

 

 

2,129

 

Write-off of assets

 

284

 

 

 

 

Loss on disposal of asset

 

 

 

 

36

 

Deferred tax (benefit) expense

 

(26

)

 

 

75

 

Stock-based compensation

 

1,876

 

 

 

2,776

 

Recovery of credit losses

 

(10

)

 

 

(453

)

Changes in operating assets and liabilities, net of the effects from acquisition:

 

 

 

Accounts receivable, net

 

24,002

 

 

 

27,756

 

Inventories, net

 

1,168

 

 

 

203

 

Contract assets

 

5,427

 

 

 

93

 

Accounts payable

 

(2,824

)

 

 

(1,437

)

Income taxes payable

 

(1,363

)

 

 

1,757

 

Accrued expenses

 

(3,482

)

 

 

(3,641

)

Deferred compensation

 

(34

)

 

 

(181

)

Deferred revenue

 

(12,583

)

 

 

(16,593

)

Other assets and liabilities

 

1,040

 

 

 

2,341

 

Net cash provided by operating activities

 

28,172

 

 

 

29,366

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Additions to property and equipment

 

(3,120

)

 

 

(1,626

)

Additions to intangible assets

 

(80

)

 

 

(19

)

Cash paid for acquisition of business, net of cash acquired

 

(34,554

)

 

 

 

Net cash used in investing activities

 

(37,754

)

 

 

(1,645

)

 

 

 

 

Cash flows from financing activities:

 

 

 

Dividends paid

 

(4,986

)

 

 

(4,587

)

Tax payments for restricted stock issuances

 

(986

)

 

 

(1,327

)

Repurchase of common stock

 

(5,401

)

 

 

 

Net cash used in financing activities

 

(11,373

)

 

 

(5,914

)

 

 

 

 

Effect of exchange rate changes on cash

 

210

 

 

 

244

 

 

 

 

 

Net (decrease) increase in cash

 

(20,745

)

 

 

22,051

 

Cash, cash equivalents, and restricted cash, beginning of period

 

70,499

 

 

 

83,331

 

Cash, cash equivalents, and restricted cash, end of period

$

49,754

 

 

$

105,382

 

Operating Segments

We report our financial results under the following two lines of business, which are our reportable operating segments: Cybersecurity and Digital Agreements.

  • Cybersecurity. Cybersecurity, formerly Security Solutions, consists of our broad portfolio of software products, software development kits (“SDKs”) and Digipass authenticator devices that are used to build applications designed to defend against attacks on digital transactions across online environments, devices, and applications. The software products and SDKs included in the Cybersecurity segment are delivered through on-premises and cloud-based deployment models and include standards-based authentication technologies such as Fast Identity Online (“FIDO”) authentication and passkeys, multi-factor authentication, transaction signing solutions and mobile application security.
  • Digital Agreements. Digital Agreements consists of solutions that enable our clients to secure and automate business processes associated with their digital agreement and customer transaction lifecycles that require consent, non-repudiation and compliance. These solutions, which are cloud-based, include OneSpan Sign e-signature, OneSpan Notary, and Identity Verification.

Segment operating income (loss) consists of the revenues generated by a segment, less the direct costs of revenue, sales and marketing, research and development expenses, general and administrative expenses, restructuring and other related charges, and amortization of intangible assets expense that are incurred directly by a segment. Sales and marketing and research and development expenses were determined to be significant segment expenses. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not directly attributable to a particular segment.

Segment and consolidated operating results (unaudited):

 

Three Months Ended March 31, 2026

(In thousands, except percentages)

Cybersecurity

 

Digital Agreements

 

Corporate and Other

 

Total

Revenue

$

48,546

 

 

$

17,401

 

 

$

 

 

$

65,947

 

Cost of goods sold

 

12,640

 

 

 

4,793

 

 

 

 

 

 

17,433

 

Gross profit

 

35,906

 

 

 

12,608

 

 

 

 

 

 

48,514

 

 

 

 

 

 

 

 

 

Gross margin

 

74

%

 

 

72

%

 

*

 

 

74

%

 

 

 

 

 

 

 

 

Sales and marketing

 

8,489

 

 

 

3,433

 

 

 

757

 

 

 

12,679

 

Research and development

 

5,941

 

 

 

2,820

 

 

 

317

 

 

 

9,078

 

Other segment items(1)(3)

 

691

 

 

 

1,073

 

 

 

10,176

 

 

 

11,940

 

Operating income (loss) (2)(4)

 

20,785

 

 

 

5,282

 

 

 

(11,250

)

 

 

14,817

 

 

 

 

 

 

 

 

 

Interest (expense) income, net

 

 

 

 

 

 

 

(19

)

Other income (expense), net

 

 

 

 

 

 

 

(386

)

Income before income taxes

 

 

 

 

 

 

$

14,412

 

 

Three Months Ended March 31, 2025

(In thousands, except percentages)

Cybersecurity

 

Digital Agreements

 

Corporate and Other

 

Total

Revenue

$

47,713

 

 

$

15,653

 

 

$

 

 

$

63,366

 

Cost of goods sold

 

11,628

 

 

 

4,647

 

 

 

 

 

 

16,275

 

Gross profit

 

36,085

 

 

 

11,006

 

 

 

 

 

 

47,091

 

 

 

 

 

 

 

 

 

Gross margin

 

76

%

 

 

70

%

 

*

 

 

74

%

 

 

 

 

 

 

 

 

Sales and marketing

 

6,872

 

 

 

3,402

 

 

 

1,183

 

 

 

11,457

 

Research and development

 

4,919

 

 

 

3,006

 

 

 

3

 

 

 

7,928

 

Other segment items(1)(3)

 

134

 

 

 

1,231

 

 

 

9,159

 

 

 

10,524

 

Operating income (loss) (2)(4)

 

24,160

 

 

 

3,367

 

 

 

(10,345

)

 

 

17,182

 

 

 

 

 

 

 

 

 

Interest (expense) income, net

 

 

 

 

 

 

 

692

 

Other income (expense), net

 

 

 

 

 

 

 

(9

)

Income before income taxes

 

 

 

 

 

 

$

17,865

 

 

*Percentage not meaningful.

(1)

 

Cybersecurity other segment items includes general and administrative expense, write-off of assets and amortization of intangibles for the three months ended March 31, 2026. Cybersecurity other segment items include general and administrative expense, restructuring and other related charges for the three months ended March 31, 2025.

 

(2)

 

Cybersecurity operating income includes $0.7 million and $0.2 million of total amortization and depreciation expense for the three months ended March 31, 2026 and 2025, respectively. Cybersecurity operating income also includes $0.3 million related to write-off of assets for the three months ended March 31, 2026. There were no write-off of assets for the three months ended March 31, 2025. Cybersecurity operating income includes $0.2 million of restructuring and other related charges for the three months ended March 31, 2025.

 

(3)

 

Digital Agreements other segment items includes general and administrative expense and amortization of intangibles for the three months ended March 31, 2026. Digital Agreements other segment items includes general and administrative expense, restructuring and other related charges for the three months ended March 31, 2025.

 

(4)

 

Digital Agreements operating income includes $2.2 million and $1.7 million of total amortization and depreciation expense for the three months ended March 31, 2026 and 2025, respectively. Digital Agreements operating income includes $0.2 million of restructuring and other related charges for the three months ended March 31, 2025.

Revenue by major products and services (unaudited):

Effective January 1, 2026, we have revised our presentation of revenue by major products and services to better align with how we manage the business and our strategic focus on growing recurring revenues. Accordingly, term maintenance revenue is now included within subscription revenue. As a result, subscription revenue now consists primarily of subscription licenses sold for on-premises software, the related maintenance and support revenue, and SaaS revenue. Additionally, maintenance revenue associated with perpetual licenses and professional services is now presented together, which reflects the steady decline in perpetual license arrangements. These changes are presentation-only and have no impact on total revenue, operating income, or cash flows, and prior-period results have been updated for comparability.

 

Three Months Ended March 31,

 

2026

 

2025

(In thousands)

Cybersecurity

 

Digital Agreements

 

Cybersecurity

 

Digital Agreements

Subscription (1)

$

35,312

 

$

17,355

 

$

33,123

 

$

15,569

Perpetual maintenance and services

 

2,647

 

 

46

 

 

3,527

 

 

84

Hardware products

 

10,587

 

 

 

 

11,063

 

 

Total Revenue

$

48,546

 

$

17,401

 

$

47,713

 

$

15,653

(1)

 

Cybersecurity and Digital Agreements Subscription revenue during the three months ended March 31, 2025 includes $5.1 million and less than $0.1 million, respectively, of term maintenance that has been reclassified from maintenance and services to align with the revised presentation of revenue as described above.

Non-GAAP Financial Measures

We report financial results in accordance with GAAP. We also evaluate our performance using certain non-GAAP financial metrics, namely Adjusted EBITDA, Non-GAAP Net Income and Non-GAAP Net Income Per Diluted Share. Our management believes that these measures, when taken together with the corresponding GAAP financial metrics, provide useful supplemental information regarding the performance of our business, as further discussed in the descriptions of each of these non-GAAP metrics below.

These non-GAAP financial measures are not measures of performance under GAAP and should not be considered in isolation or as alternatives or substitutes for the most directly comparable financial measures calculated in accordance with GAAP. While we believe that these non-GAAP financial measures are useful for the purposes described below, they have limitations associated with their use, since they exclude items that may have a material impact on our reported results and may be different from similar measures used by other companies. Additional information about the non-GAAP financial measures and reconciliations to their most directly comparable GAAP financial measures appear below.

Adjusted EBITDA

We define Adjusted EBITDA as net income before interest, taxes, depreciation, amortization, long-term incentive compensation and related payroll tax expense, restructuring and other related charges, and certain non-recurring items, including acquisition related costs, rebranding costs, and non-routine shareholder matters. We use Adjusted EBITDA as a simplified measure of performance for use in communicating our performance to investors and analysts and for comparisons to other companies within our industry. As a performance measure, we believe that Adjusted EBITDA presents a view of our operating results that is most closely related to serving our customers. By excluding interest, taxes, depreciation, amortization, long-term incentive compensation and related payroll tax expense, restructuring costs, and certain other non-recurring items, we are able to evaluate performance without considering decisions that, in most cases, are not directly related to meeting our customers’ requirements and were either made in prior periods (e.g., depreciation, amortization, long-term incentive compensation and related payroll tax expense, non-routine shareholder matters), deal with the structure or financing of the business (e.g., interest, one-time strategic action costs, restructuring costs, impairment charges) or reflect the application of regulations that are outside of the control of our management team (e.g., taxes). In addition, removing the impact of these items helps us compare our core business performance with that of our competitors.

Reconciliation of Net Income to Adjusted EBITDA

(in thousands, unaudited)

 

 

Three Months Ended March 31,

(In thousands)

2026

 

2025

Net income

$

11,565

 

$

14,505

 

Interest expense (income), net

 

19

 

 

(692

)

Provision for income taxes

 

2,847

 

 

3,360

 

Depreciation and amortization of intangible assets (1)

 

3,132

 

 

2,129

 

Long-term incentive compensation and related payroll tax expense (2)

 

2,077

 

 

3,248

 

Restructuring and other related charges (3)

 

 

 

446

 

Other non-recurring items (4)

 

1,369

 

 

39

 

Adjusted EBITDA

$

21,009

 

$

23,035

 

(1)

 

Includes cost of sales depreciation and amortization expense directly related to delivering cloud subscription revenue of $1.9 million and $1.1 million for the three months ended March 31, 2026 and 2025, respectively. Costs are recorded in “Services and other cost of goods sold” on the condensed consolidated statements of operations.

 

(2)

 

Long-term incentive compensation and related payroll tax expense includes stock-based compensation and related employer payroll tax expense, and cash incentive grants awarded to employees located in jurisdictions where we do not issue stock-based compensation due to tax, regulatory or similar reasons. The immaterial expense associated with these cash incentive grants was less than $0.1 million for the three months ended March 31, 2026 and 2025.

 

(3)

 

Costs are recorded in “Services and other cost of goods sold” and “Restructuring and other related charges,” respectively, on the condensed consolidated statements of operations.

 

 

 

Includes restructuring and other related charges of less than $0.1 million for the three months ended March 31, 2025. These charges are recorded in “Services and other cost of goods sold” on the condensed consolidated statements of operations.

 

(4)

 

For the three months ended March 31, 2026 and 2025, other non-recurring items consist of $1.4 million and less than $0.1 million, respectively, of fees related to non-recurring projects.

Non-GAAP Net Income and Non-GAAP Net Income Per Diluted Share

We define Non-GAAP Net Income and Non-GAAP Net Income Per Diluted Share as net income or net income per diluted share, as applicable, before the consideration of long-term incentive compensation expenses, the amortization of intangible assets, restructuring costs, and certain other non-recurring items. We use these measures to assess the impact of our performance excluding items that can significantly impact the comparison of our results between periods and the comparison to competitor results.

We exclude long-term incentive compensation and related payroll tax expense because our long-term incentives generally reflect the use of restricted stock unit grants or cash incentive grants, including incentives directly tied to the performance of the business, while other companies may use different forms of incentives that have different cost impacts, which makes comparison difficult. We exclude amortization of intangible assets as we believe the amount of such expense in any given period may not be correlated directly to the performance of the business operations and that such expenses can vary significantly between periods as a result of new acquisitions, the full amortization of previously acquired intangible assets, or the write down of such assets due to an impairment event. However, intangible assets contribute to current and future revenue, and related amortization expense will recur in future periods until expired or written down.

We also exclude certain non-recurring items including one-time strategic action costs and non-recurring shareholder matters, as these items are unrelated to the operations of our core business. By excluding these items, we are better able to compare the operating results of our underlying core business from one reporting period to the next.

We use a long-term projected non-GAAP tax rate of 20% for the purpose of determining our Non-GAAP Net Income and Non-GAAP Net Income Per Diluted Share to provide better consistency across interim reporting periods. We will assess the appropriate non-GAAP tax rate on a regular basis, which could be subject to change for a variety of reasons, including the rapidly evolving global tax environment, significant changes in our geographic earnings mix, or other changes to our strategy or business operations.

Reconciliation of Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended March 31,

 

2026

 

2025

Net income

$

11,565

 

 

$

14,505

 

Provision for income taxes

 

2,847

 

 

 

3,360

 

Income before income taxes

 

14,412

 

 

 

17,865

 

Long-term incentive compensation and related payroll tax expense (1)

 

2,077

 

 

 

3,248

 

Amortization of intangible assets (2)

 

698

 

 

 

556

 

Restructuring and other related charges (3)

 

 

 

 

446

 

Other non-recurring items (4)

 

1,369

 

 

 

39

 

Non-GAAP net income before income taxes

 

18,556

 

 

 

22,154

 

Non-GAAP provision for income taxes (5)

 

(3,711

)

 

 

(4,431

)

Non-GAAP net income

$

14,845

 

 

$

17,723

 

 

 

 

 

Non-GAAP net income per share, diluted

$

0.39

 

 

$

0.45

 

 

 

 

 

Weighted-average shares used to compute non-GAAP net income per share, diluted

 

38,070

 

 

 

39,027

 

(1)

 

Long-term incentive compensation and related payroll tax expense includes stock-based compensation and related employer payroll tax expense, and cash incentive grants awarded to employees located in jurisdictions where we do not issue stock-based compensation due to tax, regulatory or similar reasons. The immaterial expense associated with these cash incentive grants was less than $0.1 million for the three months ended March 31, 2026 and 2025.

 

(2)

 

Includes cost of sales amortization expense directly related to delivering cloud subscription revenue of $0.2 million for the three months ended March 31, 2026. There was no amortization expense included in cost of sales for the three months ended March 31, 2025. Costs are recorded in “Services and other cost of goods sold” on the condensed consolidated statements of operations.

 

(3)

 

Costs are recorded in “Services and other cost of goods sold” and “Restructuring and other related charges,” respectively, on the condensed consolidated statements of operations.

 
   

Includes restructuring and other related charges of less than $0.1 million for the three months ended March 31, 2025. These charges are recorded in “Services and other cost of goods sold” on the condensed consolidated statements of operations.

 

(4)

 

For the three months ended March 31, 2026 and 2025, other non-recurring items consist of $1.4 million and less than $0.1 million, respectively, of fees related to non-recurring projects.

 

(5)

 

We use a long-term projected non-GAAP tax rate of 20% for the purpose of determining our Non-GAAP Net Income and Non-GAAP Net Income Per Diluted Share to provide better consistency across interim reporting periods.

Copyright© 2026 OneSpan North America Inc., all rights reserved. OneSpan™ is a registered or unregistered trademark of OneSpan North America Inc. or its affiliates in the U.S. and other countries.

Investor Contact:

Joe Maxa

Vice President of Investor Relations

+1-312-766-4009

[email protected]

KEYWORDS: New York Massachusetts United States North America

INDUSTRY KEYWORDS: Security Apps/Applications Technology Mobile/Wireless Software Internet

MEDIA:

Logo
Logo

Rimini Street Announces Fiscal First Quarter 2026 Financial and Operating Results

Rimini Street Announces Fiscal First Quarter 2026 Financial and Operating Results

First Quarter Financial Highlights Include:

Remaining Performance Obligations (RPO) of $643.6 million, up 16.4% year over year

Adjusted Calculated Billings of $92.2 million, up 22.9% year over year

Adjusted Annualized Recurring Revenue (ARR) of $388.0 million, up 5.0% year over year

LAS VEGAS–(BUSINESS WIRE)–Rimini Street, Inc., (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal first quarter ended March 31, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430598629/en/

Rimini Street Announces Fiscal First Quarter 2026 Financial and Operating Results

Rimini Street Announces Fiscal First Quarter 2026 Financial and Operating Results

“Our first quarter results reflect continued growth and accelerating momentum in our core Rimini Support™ business as organizations turn to the proven Rimini Smart Path™ to execute their global ERP and operational transaction processes faster, better and cheaper with more agility and speed to value – all within existing budgets,” said Seth Ravin, president and CEO, Rimini Street. “We help organizations avoid unnecessary, costly and risky ERP and other enterprise software upgrades, migrations and replatformings that often deliver low ROI and little competitive advantage. Instead, organizations can invest in the modernization of their existing systems by leveraging next generation Rimini Agentic AI ERP solutions that can be quickly and economically deployed over their current ERP and other enterprise software to deliver real competitive advantage.”

“We delivered strong first quarter 2026 results that built on second half 2025 momentum, reflecting continued, growing market demand for our differentiated, proven support and innovation solutions,” said Michael Perica, CFO, Rimini Street. “We continued to make additional strategic investments in new AI and innovation offerings to drive growth and further streamlined global operations to provide leverage with scale. Looking ahead, we remain focused on profitable growth, disciplined cost management and a strong balance sheet and cash position. Capital allocation actions in the quarter included a $10 million debt prepayment that reduced outstanding debt to $58.4 million and increased net cash to $73.8 million as of March 31, 2026.”

Select First Quarter 2026 Financial Results

  • Revenue was $105.5 million for the first quarter of 2026, an increase of 1.2% compared to $104.2 million for the same period last year; excluding the support services for Oracle’s PeopleSoft software products, revenue increased by 5.2%.

  • U.S. revenue was $46.9 million for the first quarter of 2026, a decrease of 6.4% compared to $50.1 million for the same period last year; excluding the support services for Oracle’s PeopleSoft software products, U.S. revenue decreased by 0.3%.

  • International revenue was $58.6 million for the first quarter of 2026, an increase of 8.3% compared to $54.1 million for the same period last year; excluding the support services for Oracle’s PeopleSoft software products, international revenue increased by 9.9%.

  • Subscription revenue was $100.2 million, which accounted for 95.0% of total revenue for the first quarter of 2026, compared to subscription revenue of $99.0 million, which accounted for 95.0% of total revenue for the same period last year; excluding the support services for Oracle’s PeopleSoft software products, subscription revenue was $97.0 million, or 94.9% of total revenue, for the first quarter of 2026 compared to $92.4 million, or 95.0% of total revenue, for the same period last year.

  • Annualized Recurring Revenue was $400.8 million for the first quarter of 2026, an increase of 1.2% compared to $396.2 million for the same period last year; excluding the support services for Oracle’s PeopleSoft software products, Adjusted Annualized Recurring Revenue was $388.0 million for the first quarter of 2026, an increase of 5.0% compared to $369.6 million for the same period last year.

  • Active Clients as of March 31, 2026 were 3,130, an increase of 1.2% compared to 3,092 Active Clients as of March 31, 2025.

  • Revenue Retention Rate was 88% and 88% for the trailing 12 months ended March 31, 2026 and 2025, respectively.

  • Calculated Billings was $95.3 million for the first quarter of 2026, an increase of 19.9% compared to $79.4 million for the same period last year.

  • Adjusted Calculated Billings, which excludes Calculated Billings related to the support services for Oracle’s PeopleSoft software products, was $92.2 million for the first quarter of 2026, an increase of 22.9% compared to $75.0 million for the same period last year.

  • Remaining Performance Obligations (RPO) was $643.6 million as of March 31, 2026, an increase of 16.4% compared to $553.1 million as of March 31, 2025; excluding the support services for Oracle’s PeopleSoft software products, Adjusted RPO was $633.2 million as of March 31, 2026, an increase of 18.2% compared to $535.8 million as of March 31, 2025.

  • Gross margin was 59.0% for the first quarter of 2026 compared to 61.0% for the same period last year.

  • Operating income was $4.8 million for the first quarter of 2026 compared to $9.4 million for the same period last year.

  • Non-GAAP Operating Income was $7.9 million for the first quarter of 2026 compared to $14.5 million for the same period last year.

  • Net income was $1.4 million for the first quarter of 2026 compared to $3.4 million for the same period last year.

  • Non-GAAP Net Income was $4.0 million for the first quarter of 2026 compared to $9.5 million for the same period last year.

  • Adjusted EBITDA for the first quarter of 2026 was $8.9 million compared to $15.7 million for the same period last year.

  • Both the basic and diluted earnings per share attributable to common stockholders were $0.01 for the first quarter of 2026, compared to a basic and diluted earnings per share of $0.04 for the same period last year.

  • Cash and cash equivalents were $132.2 million at March 31, 2026 compared to $122.6 million at March 31, 2025.

  • Voluntary debt prepayment of $10.0 million during the first quarter, reducing the term loan outstanding to $58.4 million.

Select First Quarter 2026 Operating Results

  • Announced new and existing clients that expanded their agreements with Rimini Street, including the following:

    • LF, a leading South Korean lifestyle company, selected Rimini Support™ for SAP ECC 6.0 and Oracle Database to reduce maintenance costs, improve support quality and stability, and reinvest savings in AI-driven automation and digital transformation.
    • Cubic Corporation, a U.S. based global innovation technology partner for the defense and transportation industries, partnered with Rimini Street to support its strategy to modernize while maintaining SAP ECC as a stable core.
    • KleanNara, a leading South Korean manufacturer of paper and hygiene products, selected Rimini Support™ for its SAP ECC 6.0 and Oracle Database systems, freeing up funds and team focus for AI-driven innovation and growth.
    • Flexitech, a French manufacturer for the global automobile industry, selected Rimini Support™ for SAP to strengthen security, accelerate compliance readiness and free budget for R&D and modernization initiatives.
    • Lwart Environmental Solutions, a world leading Brazilian re-refinery and industrial sustainability organization, expanded its long-time partnership with Rimini Street by consolidating support for VMware and SAP support to regain control of its licensing and roadmap decisions, eliminating vendor-driven timelines and cost escalation.
    • Lotte Rental, South Korea’s top car rental company, selected Rimini Support™ for its SAP and Oracle systems, using the resulting savings to invest in AI, mobility services and cloud capabilities.
  • Resolved more than 6,800 support cases and delivered over 11,000 tax, legal, and regulatory updates across 23 countries, achieving an average client satisfaction score of 4.9 out of 5.0 (where 5.0 is rated excellent).

  • Received multiple industry Stevie® Awards for Best Use of AI in Customer Service, Front-Line Customer Service Team of the Year in the Technology Industry and Best Customer Satisfaction Strategy.

Business Outlook

The Company is providing second quarter 2026 revenue guidance to be in the range of $106 million to $108 million and reiterating the full year 2026 guidance provided at our Investor Day in December 2025 of revenue growth in the 4% to 6% range and Adjusted EBITDA margins in the 12.5% to 15.5% range (combined to achieve “Rule of 20”).

Webcast and Conference Call Information

Rimini Street will host a conference call and webcast to discuss the first quarter of 2026 results and offer commentary on full year 2026 at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on April 30, 2026. A live webcast of the event will be available on Rimini Street’s Investor Relations site at Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference call by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event.

Company’s Use of Non-GAAP Financial Measures

This press release contains certain “non-GAAP financial measures.” Non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by U.S. generally accepted accounting principles, or GAAP. Non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, financial measures determined in accordance with GAAP.

Reconciliations of the non-GAAP financial measures included in this press release and described below to their most directly comparable GAAP financial measures are provided in the financial tables included at the end of this press release. An explanation of these measures, why we believe they are meaningful and how they are calculated is also included under the heading “About Non-GAAP Financial Measures and Certain Key Metrics.”

About Rimini Street, Inc.

Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a proven, trusted global provider of end-to-end, mission-critical enterprise software support, managed services and innovative Agentic AI ERP solutions, and is the leading third-party support provider for Oracle, SAP and VMware software. The Company has signed thousands of IT service contracts with Fortune Global 100, Fortune 500, midmarket, public sector and government organizations who have leveraged the Rimini Smart Path™ methodology to achieve better operational outcomes, billions of US dollars in savings and fund AI and other innovation.

To learn more, please visit www.riministreet.com, and connect with Rimini Street on X, Facebook, Instagram, and LinkedIn.

Forward-Looking Statements

Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “anticipate,” “assume,” “believe,” “budget,” “continue,” “could,” “currently,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “outlook,” “plan,” “possible,” “goal,” “potential,” “predict,” “project,” “reflect,” “results,” “seem,” “seek,” “should,” “will,” “would” and other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to our ability to attract new clients or retain and/or sell additional products or services to existing clients; our ability to achieve and maintain an adequate rate of revenue growth; cost of revenue, including changes in costs associated with our efforts to grow and the results of any efforts to manage costs to align with current revenue expectations and the expansion of our offerings; the effects of increased intense competition in our industry and our ability to compete effectively; our ability to successfully educate the market regarding the advantages of our support and managed services for ERP software and to sell the products and services comprising our “Rimini Smart Path™” solutions portfolio, including but not limited to our Agentic AI ERP solutions; our intentions with respect to our pricing model and expectations of client savings relative to use of other providers; the evolution of the ERP software management and support landscape facing our clients and prospects; estimates of our total addressable market; the effects of seasonal trends on our results of operations, including the contract renewal cycles for vendor-supplied software support and managed services; the effects of the efforts of enterprise software vendors to sell upgrades or migrations to cloud-based versions of their enterprise software on our results of operations; our ability to scale our operations quickly enough to meet our clients’ changing needs or decrease our costs adequately in response to changing client demand; risks arising from incorporating artificial intelligence (“AI”) technologies into our products or services or any deficiencies associated with AI technologies used by us or by our third-party vendors and service providers; our ability to maintain, protect, and enhance our brand; the loss of one or more members of our management team and our ability to attract and retain additional qualified technical, sales and marketing personnel; our ability to expand our marketing and sales capabilities; our ability to avoid interruptions to, or degraded performance of, our services and the impact of any such interruptions or performance problems on our operations; our ability to defend against cybersecurity threats and to comply with data protection and privacy regulations; our expectations regarding new product offerings, innovation solutions, partnerships and alliance programs and our ability to develop and maintain strategic partnerships; our ability to expand internationally and the risks associated with global operations; our wind down of support services for Oracle’s PeopleSoft software products and the impact on future period revenue and costs incurred related to these efforts; the continuing impact of and our ability to comply with the terms of our July 2025 settlement agreement with Oracle; the impact of macro-economic trends, including inflation and changes in foreign exchange rates, as well as general financial, economic, regulatory and political conditions affecting the industry in which we operate and the industries in which our clients operate; our ability to generate significant capital through our operations or to raise additional capital necessary to fund and expand our operations and invest in new services and products; our business plan and our ability to effectively secure and manage our growth and associated investments; risks relating to retention rates, including our ability to accurately predict retention rates; our ability to protect our intellectual property; our ability to maintain an effective system of internal control over financial reporting; changes in laws or regulations, including tax laws or unfavorable outcomes of tax positions we take; tariff costs, including those imposed by the United States government and the potential for retaliatory trade measures by affected countries; our ability to realize benefits from our net operating losses; any negative impact of environmental, social and governance (“ESG”) matters on our reputation or business and the exposure of our business to additional costs or risks from our reporting on such matters; our credit facility’s ongoing debt service obligations and financial and operational covenants on our business and related interest rate risk; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the volatility of our stock price; the amount and timing of repurchases, if any, under our stock repurchase program and our ability to enhance stockholder value through such program; our ability to maintain our good standing with the United States government and international governments and capture new contracts with governmental entities/agencies; the occurrence of catastrophic events that may disrupt our business or that of our current and prospective clients; future acquisitions of, or investments in, complementary companies, products, subscriptions or technologies; and those discussed under the heading “Risk Factors” in Rimini Street’s Annual Report on Form 10-K filed on April 30, 2026, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the U.S. Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.

© 2026 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.

RIMINI STREET, INC.

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

 

ASSETS

March 31,

2026

 

December 31,

2025

Current assets:

 

 

 

Cash and cash equivalents

$

132,189

 

 

$

119,974

 

Restricted cash, current

 

342

 

 

 

341

 

Accounts receivable, net of allowance of $1,783 and $1,443, respectively

 

95,746

 

 

 

136,866

 

Deferred contract costs, current

 

17,570

 

 

 

17,734

 

Prepaid expenses and other

 

28,286

 

 

 

25,447

 

Total current assets

 

274,133

 

 

 

300,362

 

Long-term assets:

 

 

 

Restricted cash, noncurrent

 

784

 

 

 

785

 

Property and equipment, net of accumulated depreciation and amortization of $23,952 and $23,822, respectively

 

9,879

 

 

 

10,239

 

Operating lease right-of-use assets

 

20,494

 

 

 

21,371

 

Deferred contract costs, noncurrent

 

24,087

 

 

 

24,436

 

Deposits and other

 

8,745

 

 

 

8,379

 

Deferred income taxes, net

 

58,979

 

 

 

57,540

 

Total assets

$

397,101

 

 

$

423,112

 

LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

Current liabilities:

 

 

 

Current maturities of long-term debt

$

 

 

$

4,031

 

Accounts payable

 

4,966

 

 

 

5,752

 

Accrued compensation, benefits and commissions

 

33,747

 

 

 

39,609

 

Other accrued liabilities

 

23,475

 

 

 

24,307

 

Operating lease liabilities, current

 

4,815

 

 

 

4,984

 

Deferred revenue, current

 

257,382

 

 

 

268,717

 

Total current liabilities

 

324,385

 

 

 

347,400

 

Long-term liabilities:

 

 

 

Long-term debt, net of current maturities

 

56,412

 

 

 

63,156

 

Deferred revenue, noncurrent

 

19,947

 

 

 

18,824

 

Operating lease liabilities, noncurrent

 

17,357

 

 

 

18,843

 

Other long-term liabilities

 

1,566

 

 

 

1,918

 

Total liabilities

 

419,667

 

 

 

450,141

 

Stockholders’ deficit:

 

 

 

Preferred Stock, $0.0001 par value per share. Authorized 99,820 shares (excluding 180 shares of Series A Preferred Stock); no other series has been designated

 

 

 

 

 

Common Stock, $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 92,133 and 91,603 shares, respectively

 

9

 

 

 

9

 

Additional paid-in capital

 

184,073

 

 

 

181,075

 

Accumulated other comprehensive loss

 

(5,509

)

 

 

(5,613

)

Accumulated deficit

 

(200,023

)

 

 

(201,384

)

Treasury stock, at cost, 137 and 137 shares, respectively

 

(1,116

)

 

 

(1,116

)

Total stockholders’ deficit

 

(22,566

)

 

 

(27,029

)

Total liabilities and stockholders’ deficit

$

397,101

 

 

$

423,112

 

RIMINI STREET, INC.

Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

 

 

Three Months Ended

 

March 31,

 

 

2026

 

 

 

2025

 

Revenue

$

105,473

 

 

$

104,204

 

Cost of revenue

 

43,208

 

 

 

40,670

 

Gross profit

 

62,265

 

 

 

63,534

 

Operating expenses:

 

 

 

Sales and marketing

 

38,636

 

 

 

34,255

 

General and administrative

 

17,850

 

 

 

17,531

 

Reorganization costs

 

407

 

 

 

462

 

Research and development

 

571

 

 

 

 

Litigation costs and related recoveries:

 

 

 

Professional fees and other costs of litigation

 

 

 

 

1,925

 

Litigation costs and related recoveries, net

 

 

 

 

1,925

 

Total operating expenses

 

57,464

 

 

 

54,173

 

Operating income

 

4,801

 

 

 

9,361

 

Non-operating income and (expenses):

 

 

 

Interest expense

 

(1,251

)

 

 

(1,675

)

Other income (expenses), net

 

(1,240

)

 

 

(77

)

Income before income taxes

 

2,310

 

 

 

7,609

 

Income taxes

 

(949

)

 

 

(4,259

)

Net income

$

1,361

 

 

$

3,350

 

 

 

 

 

Net income per share attributable to common stockholders:

 

 

 

Basic

$

0.01

 

 

$

0.04

 

Diluted

$

0.01

 

 

$

0.04

 

Weighted average number of shares of Common Stock outstanding:

 

 

 

Basic

 

91,791

 

 

 

91,240

 

Diluted

 

93,918

 

 

 

93,320

 

RIMINI STREET, INC.

GAAP to Non-GAAP Reconciliations

(In thousands)

 

 

Three Months Ended

 

March 31,

 

 

2026

 

 

 

2025

 

Non-GAAP operating income reconciliation:

 

 

 

Operating income

$

4,801

 

 

$

9,361

 

Non-GAAP adjustments:

 

 

 

Litigation costs and related recoveries, net

 

 

 

 

1,925

 

Stock-based compensation expense

 

2,661

 

 

 

2,702

 

Reorganization costs

 

407

 

 

 

462

 

Non-GAAP operating income

$

7,869

 

 

$

14,450

 

Non-GAAP net income reconciliation:

 

 

 

Income before income taxes

$

2,310

 

 

$

7,609

 

Non-GAAP adjustments:

 

 

 

Litigation costs and related recoveries, net

 

 

 

 

1,925

 

Stock-based compensation expense

 

2,661

 

 

 

2,702

 

Reorganization costs

 

407

 

 

 

462

 

Non-GAAP income taxes

 

(1,328

)

 

 

(3,187

)

Non-GAAP net income

$

4,050

 

 

$

9,511

 

Non-GAAP Adjusted EBITDA reconciliation:

 

 

 

Net income

$

1,361

 

 

$

3,350

 

Non-GAAP adjustments:

 

 

 

Interest expense

 

1,251

 

 

 

1,675

 

Income taxes

 

949

 

 

 

4,259

 

Depreciation and amortization expense

 

995

 

 

 

930

 

EBITDA

 

4,556

 

 

 

10,214

 

Non-GAAP adjustments:

 

 

 

Litigation costs and related recoveries, net

 

 

 

 

1,925

 

Stock-based compensation expense

 

2,661

 

 

 

2,702

 

Reorganization costs

 

407

 

 

 

462

 

Unrealized foreign exchange losses

 

1,281

 

 

 

400

 

Adjusted EBITDA

$

8,905

 

 

$

15,703

 

Calculated Billings:

 

 

 

Revenue

$

105,473

 

 

$

104,204

 

Deferred revenue, current and noncurrent, end of the period

 

277,329

 

 

 

256,423

 

Deferred revenue, current and noncurrent, beginning of the period

 

287,541

 

 

 

281,197

 

Change in deferred revenue

 

(10,212

)

 

 

(24,774

)

Calculated billings

 

95,261

 

 

 

79,430

 

Less PeopleSoft calculated billings

 

(3,063

)

 

 

(4,426

)

Adjusted calculated billings

$

92,198

 

 

$

75,004

 

RIMINI STREET, INC.

GAAP to Non-GAAP Reconciliations

(In thousands)

 

 

 

Three Months Ended

 

 

March 31,

 

 

2026

 

2025

Annualized recurring revenue

 

$

400,812

 

$

396,156

Less annualized PeopleSoft recurring revenue

 

 

12,768

 

 

26,572

Adjusted annualized recurring revenue

 

$

388,044

 

$

369,584

 

 

 

 

 

 

 

March 31, 2026

 

March 31, 2025

Remaining performance obligations

 

$

643,614

 

$

553,070

Less PeopleSoft remaining performance obligations

 

 

10,399

 

 

17,257

Adjusted remaining performance obligations

 

$

633,215

 

$

535,813

About Non-GAAP Financial Measures and Certain Key Metrics

To provide investors and others with additional information regarding Rimini Street’s results, we have disclosed the following non-GAAP financial measures and certain key metrics. We have described below Active Clients, Annualized Recurring Revenue, Adjusted Annualized Recurring Revenue and Revenue Retention Rate, each of which is a key operational metric for our business. In addition, we have disclosed the following non-GAAP financial measures: non-GAAP operating income, non-GAAP net income, EBITDA, Adjusted EBITDA, Calculated Billings, Adjusted Calculated Billings, Remaining Performance Obligations and Adjusted Remaining Performance Obligations. In addition, we present certain financial metrics excluding our Oracle’s PeopleSoft software product offering to permit investors to see the operation of our continuing business, excluding reductions associated with the PeopleSoft wind down. Rimini Street has provided in the tables above a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. These non-GAAP financial measures are also described below.

The primary purpose of using non-GAAP measures is to provide supplemental information that management believes may prove useful to investors and to enable investors to evaluate our results in the same way management does. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, management uses these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware however, that not all companies define these non-GAAP measures consistently.

Active Client is a distinct entity that purchases our services to support a specific product, including a company, an educational or government institution, or a business unit of a company. For example, we count as two separate active clients when support for two different products is being provided to the same entity. We believe that our ability to expand our active clients is an indicator of the growth of our business, the success of our sales and marketing activities, and the value that our services bring to our clients.

Annualized Recurring Revenue is the amount of subscription revenue recognized during a fiscal quarter and multiplied by four. This gives us an indication of the revenue that can be earned in the following 12-month period from our existing client base, assuming no cancellations or price changes occur during that period. Subscription revenue excludes any non-recurring revenue, which has been insignificant to date.

Adjusted Annualized Recurring Revenue is annualized recurring revenue adjusted to exclude subscription revenue associated with services for Oracle’s PeopleSoft software products recognized during a fiscal quarter and multiplied by four.

Revenue Retention Rate is the actual subscription revenue (dollar-based) recognized over a 12-month period from customers that were clients on the day prior to the start of such 12-month period, divided by our Annualized Recurring Revenue as of the day prior to the start of the 12-month period.

Non-GAAP Operating Income is operating income adjusted to exclude: litigation costs and related recoveries, net, stock-based compensation expense and reorganization costs. The exclusions are discussed in further detail below.

Non-GAAP Income Taxes is the income tax effect adjusted to exclude: litigation costs and related recoveries, net, stock-based compensation expense and reorganization costs from income before income taxes.

Non-GAAP Net Income is net income adjusted to exclude: litigation costs and related recoveries, net, stock-based compensation expense and reorganization costs after taxes. These exclusions are discussed in further detail below.

Specifically, management excludes the following items from its non-GAAP financial measures, as applicable, for the periods presented:

Litigation Costs and Related Recoveries, Net: Litigation costs and the associated litigation settlement, insurance and appeal recoveries relate to outside costs of litigation activities. These costs and recoveries reflect the litigation we are involved with, and do not relate to the day-to-day operations or our core business of serving our clients.

Stock-Based Compensation Expense: Our compensation strategy includes the use of stock-based compensation to attract and retain employees. This strategy is principally aimed at aligning employee interests with those of our stockholders and to achieve long-term employee retention. As a result, stock-based compensation expense varies for reasons that are generally unrelated to operational decisions in any particular period.

Reorganization Costs: The costs consist primarily of severance costs associated with the Company’s reorganization plan.

EBITDA is net income adjusted to exclude: interest expense, income taxes, and depreciation and amortization expense.

Adjusted EBITDA is EBITDA adjusted to exclude: litigation costs and related recoveries, net, stock-based compensation expense and reorganization costs, as discussed above. In addition, it is also adjusted by unrealized foreign exchange (gains) or losses.

Calculated Billings represents the change in deferred revenue for the current period plus revenue for the current period.

Adjusted Calculated Billings is calculated billings adjusted to exclude the calculated billings associated with services for Oracle’s PeopleSoft software products.

Remaining Performance Obligations represent all future non-cancellable revenue under contract that has not yet been recognized as revenue, and includes deferred revenue and unbilled amounts.

Adjusted Remaining Performance Obligations is the Company’s remaining performance obligations adjusted to exclude the remaining performance obligations for services for Oracle’s PeopleSoft software products.

Rule of 20 is achieved when the revenue growth percentage and adjusted EBITDA percentage of revenue equal 20% when added together.

Investor Relations Contact

Dean Pohl

Rimini Street, Inc.

+1 925 523-7636

[email protected]

Media Relations Contact

Janet Ravin

Rimini Street, Inc.

+1 702 285-3532

[email protected]

KEYWORDS: Nevada United States North America

INDUSTRY KEYWORDS: Data Management Technology Software Networks Artificial Intelligence Internet Hardware

MEDIA:

Photo
Photo
Rimini Street Announces Fiscal First Quarter 2026 Financial and Operating Results
Logo
Logo

Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

NEW YORK–(BUSINESS WIRE)–
Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EDT on Thursday, May 7, 2026 to report financial results for the first quarter ended March 31, 2026, and discuss recent business highlights.

Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the Investor Relations section of the Definium Therapeutics website, ir.definiumtx.com, and archived for at least 30 days after the webcast. Those who plan on participating are advised to join 15 minutes prior to the start time.

About Definium Therapeutics

The mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Guided by a recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

For more information, visit https://definiumtx.com/ and follow Definium Therapeutics on Instagram, LinkedIn and X.

Investor Contact:

Gitanjali Jain

VP, Head of Investor Relations

[email protected]

Media Contact:

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Mental Health Health Neurology Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Logo
Logo

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

Mdxhealth to Release First Quarter 2026 Financial Results on May 13


Company to Host Conference Call with Live Q&A, May 13, 2026, at 4:30pm ET / 22:30 CET

IRVINE, California – April 30, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Wednesday, May 13, 2026.

Title:

Mdxhealth Presents First Quarter 2026 Financial Results and
Corporate Update Conference Call and Webcast
Date: May 13, 2026
Time: 4:30pm ET/ 22:30 CET
Conference Call D
ial-in
Details:

United States: 1-800-245-3047
Belgium: 0800 72 519
United Kingdom: 0808 101 1183

Conference ID:         MDX1Q26
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1758088&tp_key=21da6e9d38

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.

About Mdxhealth

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:

[email protected]

LifeSci Advisors (IR & PR)

John Fraunces, Managing Director
Tel: +1 917 355 2395
[email protected]

Attachment



Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units

All dollar references are in U.S. dollars, unless noted otherwise. 

BROOKFIELD NEWS, April 30, 2026 (GLOBE NEWSWIRE) — Brookfield Property Partners (“BPY” or the “Partnership”) announced today that the Board of Directors has declared quarterly distributions on the Partnership’s Class A Nasdaq-listed BPYPP, BPYPO, BPYPN and BPYPM (TSX: BPYP.PR.A) preferred units of $0.40625 per unit, $0.3984375 per unit, $0.359375 per unit and $0.390625 per unit, respectively, payable on June 30, 2026, to holders of record at the close of business on June 1, 2026.

Brookfield Property Partners

Brookfield Property Partners is one of the world’s premier real estate companies. We own and operate iconic properties in the world’s major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, single-family rentals, manufactured housing, student housing and self-storage.

Brookfield Property Partners is a subsidiary of Brookfield Corporation (NYSE: BN, TSX: BN). More information is available at www.brookfield.com.


Contact:                                                                                                                                                                                                                                                                                                                                                                     
Keren Dubon
Investor Relations
Tel.: (212) 618-3440
Email: [email protected]



BayFirst Financial Corp. Announces Substantial Capital Raise, Names Alfred Rogers as Bank Chief Executive Officer, and Reports First Quarter 2026 Results

ST. PETERSBURG, Fla., April 30, 2026 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or “Company”), parent company of BayFirst National Bank (“Bank”) today reported the Company has raised $80 million of capital from investors in a private investment in public equity (“PIPE”) offering. The Company has issued shares of convertible preferred stock in the PIPE, which subject to shareholder and regulatory approvals, will convert to, or be exchanged for, approximately 22.9 million shares of common stock at an effective purchase price of $3.50 per share.

Additionally, the Company reported a net loss of $5.7 million, or $1.48 per common share and diluted common share, for the first quarter of 2026, compared to a net loss of $2.5 million, or $0.69 per common share and diluted common share, in the fourth quarter of 2025.

“Today we announce a substantial recapitalization of BayFirst Financial Corp. and BayFirst National Bank,” stated Anthony Saravanos, Chairman of the Board of Directors. “This successful capital raise reflects the trust our investors place in our institution and our long-term strategic direction. I am also pleased to announce that the Board has elected Alfred Rogers as Chief Executive Officer and President of the Bank, in place of Tom Zernick who is retiring. Al is a veteran banker who is well respected across the Tampa Bay market. He served as CEO of Manufacturers Bank of Florida and most recently as Executive Vice President and Chief Lending Officer of USAmeribank, which was acquired by Valley National Bank.

“The Board of Directors believe that Al’s experience and leadership, combined with this capital raise, will lead BayFirst back to profitability and growth as the premier financial institution of Tampa Bay.”

“I am excited to begin my next chapter with the Board and the Bank’s leadership at BayFirst,” said Rogers. “While progress has been made with our focus on Community Banking, much work lies ahead for us. Our terrific network of branches and dedicated people are the ideal foundation for BayFirst to become the community bank of choice in our market. I’ve been proud to have led several community banks in our area, with each serving and growing local businesses and retail customers. BayFirst has that same dedication to this community, and I’m looking forward to rolling up my sleeves with the team to accomplish great things right here in our backyard.”

Saravanos concluded, “the Board of Directors have made additional decisions, including the resumption of dividend payments to our preferred shareholders and will formally redeem the Series A preferred shares. Furthermore, the Board has appointed Kenneth R. Lehman as a member of the Boards.” Mr. Rogers’ appointment to the Board of Directors of the Bank and as Chief Executive Officer have received all necessary regulatory approvals and became effective upon the completion of the capital raise. The appointments of Mr. Rogers as CEO and President of the Company, as well as a director, is contingent upon receipt of regulatory non-objections. Mr. Lehman’s appointment to the Boards of Directors of the Company and the Bank are contingent upon receipt of regulatory non-objections.

First Quarter 2026 Performance Review

  • Net interest margin was 3.42% in the first quarter of 2026, a decrease of 16 basis points from 3.58% in the fourth quarter of 2026 and a decrease of 35 basis points from 3.77% in the first quarter of 2025.
  • Loans held for investment decreased by $33.5 million, or 3.5%, during the first quarter of 2026 to $930.4 million and decreased $154.4 million, or 14.2%, over the past year. The decrease from the prior year was partially the result of the sale of $97.4 million of government guaranteed loans to Banesco USA as part of the Bank’s discontinuance of SBA 7(a) lending.
  • Deposits decreased $98.1 million, or 8.3%, during the first quarter of 2026 and decreased $42.4 million, or 3.8%, over the past year to $1.09 billion. The decrease in deposits during the quarter was primarily due to decreases in interest-bearing transaction account balances, savings and money market account balances, and time deposit balances, partially offset by an increase in noninterest-bearing account balances.
  • Book value and tangible book value at March 31, 2026 were $15.74 per common share, a decrease from $17.22 at December 31, 2025.

Results of Operations

Net Loss

The Company had a net loss of $5.7 million for the first quarter of 2026, compared to a net loss of $2.5 million in the fourth quarter of 2025 and a net loss of $0.3 million in the first quarter of 2025. The change in the first quarter of 2026 from the preceding quarter was primarily the result of a decrease of $1.7 million in net interest income, an increase in provision for credit losses of $1.1 million, and an increase in noninterest expense of $3.0 million. This was partially offset by an increase in noninterest income of $1.0 million and a decrease in income tax benefit of $1.6 million. The change from the first quarter of 2025 was due to a decrease in net interest income of $1.6 million, a decrease in noninterest income of $7.9 million, partially offset by a decrease in provision for credit losses of $1.3 million, a decrease in noninterest expense of $0.9 million, and a decrease in income tax expenses of $1.8 million.

Net Interest Income and Net Interest Margin

Net interest income was $9.4 million in the first quarter of 2026, a decrease from $11.2 million during the fourth quarter of 2025, and a decrease from $11.0 million during the first quarter of 2025. The net interest margin was 3.42% in the first quarter of 2026, a decrease of 16 basis points from 3.58% in the fourth quarter of 2025 and a decrease of 35 basis points from 3.77% in the first quarter of 2025.

The decrease in net interest income during the first quarter of 2026, as compared to the fourth quarter of 2025, was mainly due to a decrease in loan interest income, including fees, of $3.4 million, partially offset by a decrease in interest expense of $1.8 million.

The decrease in net interest income during the first quarter of 2026, as compared to the year ago quarter, was mainly due to a decrease in loan interest income, including fees, of $3.8 million, partially offset by an increase in interest income on interest bearing deposits in banks and other of $0.6 million and a decrease in interest expense on deposits of $1.5 million.

Noninterest Income

Noninterest income was $0.9 million for the first quarter of 2026, compared to a negative $0.1 million in the fourth quarter of 2025 and $8.8 million in the first quarter of 2025. The change from the first quarter of 2026, as compared to the fourth quarter of 2025, was primarily the result an increase in government guaranteed loan fair value gains of $1.3 million. The decrease in the first quarter of 2026, as compared to the first quarter of 2025, was the result a decrease in gain on sale of government guaranteed loans of $7.4 million and a decrease in government guaranteed loan packaging fees of $0.7 million.

Noninterest Expense

Noninterest expense was $14.9 million in the first quarter of 2026 compared to $11.9 million in the fourth quarter of 2025 and $15.8 million in the first quarter of 2025. The increase in the first quarter of 2026, as compared to the prior quarter, was primarily due to an increase in loan servicing and origination expense of $2.7 million. The decrease in the first quarter of 2026, as compared to the first quarter of 2025, was primarily due to a decrease in compensation expense of $2.7 million and a decrease in data processing expenses of $0.6 million, partially offset by an increase in loan servicing and origination expense of $2.8 million.

Balance Sheet

Assets

Total assets decreased $104.3 million, or 8.0%, during the first quarter of 2026 to $1.20 billion, mainly due to a decrease in cash and cash equivalents of $72.5 million. and a decrease in loans held for investment of $33.5 million. Compared to the end of the first quarter last year, total assets decreased $96.0 million, or 7.4%, driven primarily by a decrease in loans held for investment of $154.4 million, partially offset by a decrease in cash and cash equivalents of $71.3 million.

Loans

Loans held for investment decreased $33.5 million, or 3.5%, during the first quarter of 2026 and $154.4 million, or 14.2%, over the past year to $930.4 million. The decrease from prior year was primarily due to loan payoffs and government guaranteed loan sales, which included the sale of the SBA 7(a) loans to Banesco USA as part of the Bank’s discontinuance of SBA 7(a) lending. This was partially offset by originations in both conventional community bank loans and government guaranteed loans.

Deposits

Deposits decreased $98.1 million, or 8.3%, during the first quarter of 2026 and decreased $42.4 million, or 3.8%, from the first quarter of 2025, ending March 31, 2026, at $1.09 billion. During the first quarter, there were decreases in interest-bearing transaction account balances of $77.4 million savings and money market account balances of $21.9 million, and time deposit balances of $14.6 million, partially offset by an increase in noninterest-bearing account balances of $15.7 million. The decrease in deposits during the quarter was primarily due to reductions in high-rate promotional deposits held with non-relationship customers and also a decrease in brokered deposits. During the first quarter, the Bank reduced cost of funds by 27 basis points. At March 31, 2026, approximately 83% of total deposits were insured by the FDIC. At March 31, 2026, December 31, 2025, and March 31, 2025, the Company had $183.9 million, $195.5 million, and $112.3 million, respectively, of brokered deposits.

Asset Quality

The Company recorded a provision for credit losses in the first quarter of $3.1 million, compared to provisions of $2.0 million for the fourth quarter of 2025 and $4.4 million during the first quarter of 2025.

The ratio of allowance for credit losses (ACL) on loans to total loans held for investment at amortized cost was 2.35% at March 31, 2026, 2.42% as of December 31, 2025, and 1.61% as of March 31, 2025. The ratio of ACL to total loans held for investment at amortized cost, excluding government guaranteed loan balances, was 2.53% at March 31, 2026, 2.58% as of December 31, 2025, and 1.84% as of March 31, 2025. The increase in the ACL ratios from the prior year was the result of increases in nonperforming loans and continued economic uncertainty.

Net charge-offs for the first quarter of 2026 were $4.4 million, which was a decrease from $4.6 million for the fourth quarter of 2025 and an increase from $3.3 million for the first quarter of 2025. Annualized net charge-offs as a percentage of average loans held for investment at amortized cost were 1.98% for the first quarter of 2026, compared to 1.94% in the fourth quarter of 2025 and 1.28% in the first quarter of 2025. Nonperforming assets were 2.00% of total assets as of March 31, 2026, compared to 2.04% as of December 31, 2025, and 2.08% as of March 31, 2025. Nonperforming assets, excluding government guaranteed loan balances, were 1.38% of total assets as of March 31, 2026, compared to 1.29% as of December 31, 2025, and 1.22% as of March 31, 2025.

Capital

The Bank’s Tier 1 leverage ratio was 6.54% as of March 31, 2026, compared to 6.52% as of December 31, 2025, and 8.56% as of March 31, 2025. The CET 1 and Tier 1 capital ratios to risk-weighted assets were 8.58% as of March 31, 2026, compared to 8.92% as of December 31, 2025, and 10.47% as of March 31, 2025. The total capital to risk-weighted assets ratio was 9.84% as of March 31, 2026, compared to 10.18% as of December 31, 2025, and 11.73% as of March 31, 2025. At March 31, 2026, the Bank did not meet all of its regulatory capital requirements to be well-capitalized but the consummation of the capital raise is intended to meet these capital requirements going forward.

Impact of Capital Raise

On a proforma basis, giving effect to a $42 million capital contribution from the Company to the Bank, it’s Tier 1 leverage ratio was 10.02% as of March 31, 2026. The CET 1 and Tier 1 capital ratios to risk-weighted assets were 13.13% as of March 31, 2026. The total capital to risk-weighted assets ratio was 14.40% as of March 31, 2026.

Liquidity

The Bank’s overall liquidity position remains strong and stable with liquidity in excess of internal minimums as stated by policy and monitored by management and the Board. The on-balance sheet liquidity ratio at March 31, 2026 was 13.85%, as compared to 18.35% at December 31, 2025. The Bank has liquidity resources which include secured borrowings available from the Federal Home Loan Bank, the Federal Reserve, and lines of credit with other financial institutions. As of March 31, 2026 and December 31, 2025, the Bank had no borrowings from the FHLB, the FRB or other financial institutions.

Recent Events

Following the closing of the PIPE, the Company intends to identify certain criticized assets and develop an Asset Resolution Plan. The Asset Resolution Plan will provide a work-out strategy for identified assets for subsequent disposition, work-out, upgrade, or other resolution.

On April 30, 2026, the Company filed a registration statement on Form S-1 regarding the public offering of up to 4,108,072 shares of Common Stock at an offering price of $3.50 per share. The Company intends to exclusively market this offering to its shareholders of record on May 12, 2026.

Hovde Group, LLC is acting as sole placement agent for the PIPE. Igler and Pearlman, P.A. is serving as legal counsel to the Company, and Alston & Bird LLP, is serving as legal counsel to the placement agent.

Special Meeting of Shareholders

A special meeting of shareholders is scheduled for July 14, 2026 at 8:30 a.m. to approve an amendment to the Company’s articles of incorporation to increase the number of authorized shares to permit the conversion and exchange of the preferred stock issued in the PIPE and the conversion of such preferred stock into shares of common stock.

The Company intends to file a proxy statement with the SEC that will be sent to Company shareholders seeking their approval of the transactions described above. Shareholders are urged to read the proxy statement when it becomes available (and any other relevant documents filed with the SEC in connection with the transactions described herein) because such documents will contain important information regarding the Company, the transactions, certain investors in the transactions, and related matters.

Shareholders may obtain free copies of these documents, once they are filed, and other documents filed with the SEC by the Company through the website maintained by the SEC at http://www.sec.gov. Investors and security holders will also be able to obtain these documents, once they are filed, free of charge, by requesting them in writing from [email protected], or by telephone at (727) 440-6848. The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Company shareholders. Information about Company directors and executive officers and their ownership of Company common stock is set forth in the Company’ Form 10-K for the year ended December 31, 2025, as previously filed with the SEC on March 27, 2026.

Certain investments discussed above involve the sale of securities in private transactions that will not be registered under the Securities Act of 1933, as amended, and will be subject to the resale restrictions under that Act. Such securities may not be offered or sold absent registration or an applicable exemption from registration. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Conference Call

BayFirst will host a conference call on Friday, May 1, 2026, at 9:00 a.m. ET to discuss its first quarter results. Interested parties may listen to the call live under the Investor Relations tab at www.bayfirstfinancial.com or are invited to dial (800) 549-8228 to participate in the call using Conference ID 37957. A replay of the call will be available for one year at www.bayfirstfinancial.com.

About BayFirst Financial Corp.

BayFirst Financial Corp. is a registered bank holding company based in St. Petersburg, Florida which commenced operations on September 1, 2000. Its primary source of income is derived from its wholly owned subsidiary, BayFirst National Bank, a national banking association which commenced business operations on February 12, 1999. The Bank currently operates twelve full-service banking offices throughout the Tampa Bay-Sarasota region and offers a broad range of commercial and consumer banking services to businesses and individuals. As of March 31, 2026, BayFirst Financial Corp. had $1.20 billion in total assets.

Forward-Looking Statements

In addition to the historical information contained herein, this presentation includes “forward-looking statements” within the meaning of such term in the Private Securities Litigation Reform Act of 1995. These statements are subject to many risks and uncertainties, including, but not limited to, the effects of health crises, global military hostilities, weather events, or climate change, including their effects on the economic environment, our customers and our operations, as well as any changes to federal, state or local government laws, regulations or orders in connection with them; the ability of the Company to implement its strategy and expand its banking operations; changes in interest rates and other general economic, business and political conditions, including changes in the financial markets and credit quality; changes in business plans as circumstances warrant; risks related to mergers and acquisitions; changes in benchmark interest rates used to price loans and deposits, changes in tax laws, regulations and guidance; enforcement actions initiated by our regulators and their impact on our operations; and other risks detailed from time to time in filings made by the Company with the SEC, including, but not limited to those “Risk Factors” described in our most recent Form 10-K and Form 10-Q. Readers should note that the forward-looking statements included herein are not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking statements.

Forward-looking statements generally can be identified by the use of forward-looking terminology such as “will,” “propose,” “may,” “plan,” “seek,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “continue,” or similar terminology. Any forward-looking statements presented herein are made only as of the date of this document, and the Company does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

   
BAYFIRST FINANCIAL CORP.
SELECTED FINANCIAL DATA (Unaudited)
   
  At or for the three months ended
(Dollars in thousands, except for share data) 3/31/2026   12/31/2025   9/30/2025   6/30/2025   3/31/2025
Net loss $ (5,680 )   $ (2,463 )   $ (18,902 )   $ (1,237 )   $ (335 )
Balance sheet data:                  
Average loans held for investment at amortized cost   887,756       939,281       1,060,520       1,047,568       1,027,648  
Average total assets   1,219,748       1,334,912       1,345,553       1,324,455       1,287,618  
Average common shareholders’ equity   70,373       73,470       92,734       95,049       96,053  
Government guaranteed loans held for sale               94,052              
Total loans held for investment   930,426       963,894       998,683       1,125,799       1,084,817  
Total loans held for investment, excl gov’t gtd loan balances   855,363       893,765       923,390       972,942       943,979  
Allowance for credit losses   20,632       21,996       24,485       17,041       16,513  
Total assets   1,195,910       1,300,258       1,345,978       1,343,867       1,291,957  
Total deposits   1,085,869       1,183,938       1,171,457       1,163,796       1,128,267  
Common shareholders’ equity   64,660       70,747       73,677       92,172       94,034  
Share data:                  
Basic loss per common share $ (1.48 )   $ (0.69 )   $ (4.66 )   $ (0.39 )   $ (0.17 )
Diluted loss per common share   (1.48 )     (0.69 )     (4.66 )     (0.39 )     (0.17 )
Dividends per common share                     0.08       0.08  
Book value per common share   15.74       17.22       17.90       22.30       22.77  
Tangible book value per common share(1)   15.74       17.22       17.90       22.30       22.77  
Performance ratios:                  
Return on average assets(2) (1.86 )%   (0.74 )%   (5.62 )%   (0.37 )%   (0.10 )%
Return on average common equity(2) (34.47 )%   (15.51 )%   (83.19 )%   (6.83 )%   (3.00 )%
Net interest margin(2)   3.42 %     3.58 %     3.61 %     4.06 %     3.77 %
Asset quality ratios:                  
Net charge-offs $ 4,393     $ 4,558     $ 3,294     $ 6,799     $ 3,301  
Net charge-offs/avg loans held for investment at amortized cost(2)   1.98 %     1.94 %     1.24 %     2.60 %     1.28 %
Nonperforming loans(3) $ 21,453     $ 24,343     $ 24,687     $ 21,665     $ 24,806  
Nonperforming loans (excluding gov’t gtd balance)(3) $ 15,873     $ 16,271     $ 15,822     $ 14,187     $ 15,078  
Nonperforming loans/total loans held for investment(3)   2.44 %     2.68 %     2.63 %     2.09 %     2.42 %
Nonperforming loans (excl gov’t gtd balance)/total loans held for investment(3)   1.81 %     1.79 %     1.69 %     1.37 %     1.47 %
ACL/Total loans held for investment at amortized cost   2.35 %     2.42 %     2.61 %     1.65 %     1.61 %
ACL/Total loans held for investment at amortized cost, excl government guaranteed loans   2.53 %     2.58 %     2.78 %     1.85 %     1.84 %
Other Data:                  
Full-time equivalent employees   143       144       237       300       305  
Banking center offices   12       12       12       12       12  
(1) See section entitled “GAAP Reconciliation and Management Explanation of Non-GAAP Financial Measures” below for a reconciliation to most comparable GAAP equivalent.
(2) Annualized
(3) Excludes loans measured at fair value
                   

Reconciliation and Management Explanation of Non-GAAP Financial Measures

Some of the financial measures included in this report are not measures of financial condition or performance recognized by GAAP. These non-GAAP financial measures include tangible common shareholders’ equity and tangible book value per common share. Our management uses these non-GAAP financial measures in its analysis of our performance, and we believe that providing this information to financial analysts and investors allows them to evaluate capital adequacy.

The following presents the calculation of the non-GAAP financial measures.

Tangible Common Shareholders’ Equity and Tangible Book Value Per Common Share (Unaudited)
  As of
(Dollars in thousands, except for share data) March 31, 2026   December 31, 2025   September 30, 2025   June 30, 2025   March 31, 2025
Total shareholders’ equity $ 81,867     $ 87,569     $ 89,728     $ 108,223     $ 110,085  
Less: Preferred stock liquidation preference   (17,207 )     (16,822 )     (16,051 )     (16,051 )     (16,051 )
Total equity available to common shareholders   64,660       70,747       73,677       92,172       94,034  
Less: Goodwill                            
Tangible common shareholders’ equity $ 64,660     $ 70,747     $ 73,677     $ 92,172     $ 94,034  
                   
Common shares outstanding   4,108,072       4,108,069       4,116,913       4,134,127       4,129,027  
Tangible book value per common share $ 15.74     $ 17.22     $ 17.90     $ 22.30     $ 22.77  
                                       

BAYFIRST FINANCIAL CORP.
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands) 3/31/2026 12/31/2025 3/31/2025
Assets Unaudited   Unaudited
Cash and due from banks $ 6,848   $ 5,123   $ 6,517  
Interest-bearing deposits in banks   127,617     201,859     56,637  
Cash and cash equivalents   134,465     206,982     63,154  
Time deposits in banks           2,025  
Investment securities available for sale, at fair value (amortized cost $31,267, $31,974, and $39,507 at March 31, 2026, December 31, 2025, and March 31, 2025, respectively)   28,531     29,363     36,318  
Investment securities held to maturity, at amortized cost, net of allowance for credit losses of $10, $7, and $12 (fair value: $2,378, $2,384, and $2,356 at March 31, 2026, December 31, 2025, and March 31, 2025, respectively)   2,490     2,493     2,488  
Nonmarketable equity securities   4,662     4,656     5,480  
Government guaranteed loans held for investment, at fair value   51,807     54,076     57,901  
Loans held for investment, at amortized cost   878,619     909,818     1,026,916  
Allowance for credit losses on loans   (20,632 )   (21,996 )   (16,513 )
Net Loans held for investment, at amortized cost   857,987     887,822     1,010,403  
Accrued interest receivable   7,683     8,421     9,153  
Premises and equipment, net   30,690     31,188     32,769  
Loan servicing rights   11,334     12,580     16,460  
Deferred income tax assets   8,489     6,538      
Right-of-use operating lease assets   14,171     14,504     15,484  
Bank owned life insurance   27,457     27,264     26,696  
Other real estate owned   400     400     132  
Other assets   15,744     13,971     13,494  
Total assets $ 1,195,910   $ 1,300,258   $ 1,291,957  
Liabilities:      
Noninterest-bearing deposit accounts $ 111,476   $ 95,731   $ 106,236  
Interest-bearing transaction accounts   153,860     231,227     261,074  
Savings and money market deposit accounts   432,781     454,639     467,766  
Time deposits   387,752     402,341     293,191  
Total deposits   1,085,869     1,183,938     1,128,267  
FHLB borrowings           20,000  
Subordinated debentures   6,099     5,962     5,957  
Notes payable   1,479     1,593     1,820  
Accrued interest payable   958     1,133     1,053  
Operating lease liabilities   13,003     13,264     14,102  
Deferred income tax liabilities           648  
Accrued expenses and other liabilities   6,635     6,799     10,025  
Total liabilities   1,114,043     1,212,689     1,181,872  
Shareholders’ equity: Unaudited   Unaudited
Preferred stock, Series A; no par value, 10,000 shares authorized, 6,395 shares issued and outstanding at March 31, 2026, December 31, 2025, and March 31, 2025; aggregate liquidation preference of $6,683 at December 31, 2025 and March 31, 2025, and $6,827 at March 31, 2026   6,161     6,161     6,161  
Preferred stock, Series B; no par value, 20,000 shares authorized, 3,210 shares issued and outstanding at March 31, 2026, December 31, 2025, and March 31, 2025; aggregate liquidation preference of $3,338 at December 31, 2025 and March 31, 2025 and $3,402 at March 31, 2026   3,123     3,123     3,123  
Preferred stock, Series C; no par value, 10,000 shares authorized, 6,446 shares issued and outstanding at March 31, 2026, December 31, 2025, and March 31, 2025; aggregate liquidation preference of $6,801 at December 31, 2025 and March 31, 2025 and $6,978 at March 31, 2026   6,446     6,446     6,446  
Common stock and additional paid-in capital; no par value, 15,000,000 shares authorized, 4,108,072, 4,108,609, and 4,129,027 shares issued and outstanding at March 31, 2026, December 31, 2025, and March 31, 2025, respectively   54,390     54,371     54,657  
Accumulated other comprehensive loss, net   (2,054 )   (1,960 )   (2,378 )
Unearned compensation   (282 )   (335 )   (1,006 )
Retained earnings   14,083     19,763     43,082  
Total shareholders’ equity   81,867     87,569     110,085  
Total liabilities and shareholders’ equity $ 1,195,910   $ 1,300,258   $ 1,291,957  
                   

BAYFIRST FINANCIAL CORP.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
  For the Quarter Ended
(Dollars in thousands, except per share data) 3/31/2026   12/31/2025   3/31/2025
Interest income:          
Loans, including fees $ 15,930     $ 19,326     $ 19,751  
Interest-bearing deposits in banks and other   1,509       1,624       934  
Total interest income   17,439       20,950       20,685  
Interest expense:          
Deposits   7,893       9,451       9,431  
Other   97       341       255  
Total interest expense   7,990       9,792       9,686  
Net interest income   9,449       11,158       10,999  
Provision for credit losses   3,078       2,007       4,400  
Net interest income after provision for credit losses   6,371       9,151       6,599  
Noninterest income:          
Loan servicing income, net   770       788       736  
Gain (loss) on sale of government guaranteed loans, net   (97 )     290       7,327  
Service charges and fees   490       471       449  
Government guaranteed loans fair value loss, net   (533 )     (1,880 )     (755 )
Government guaranteed loan packaging fees         95       716  
Gain on sale of premises and equipment   13              
Other noninterest income   241       132       278  
Total noninterest income   884       (104 )     8,751  
Noninterest Expense:          
Salaries and benefits   5,069       4,681       7,998  
Bonus, commissions, and incentives   290       (8 )     71  
Occupancy and equipment   1,368       1,330       1,634  
Data processing   1,489       1,687       2,045  
Marketing and business development   123       281       487  
Professional services   1,164       1,083       732  
Loan servicing and origination expense   3,836       1,135       1,035  
Employee recruiting and development   202       210       617  
Regulatory assessments   578       694       339  
Restructure charges         21        
Other noninterest expense   767       755       855  
Total noninterest expense   14,886       11,869       15,813  
Loss before taxes   (7,631 )     (2,822 )     (463 )
Income tax benefit   (1,951 )     (359 )     (128 )
Net loss   (5,680 )     (2,463 )     (335 )
Preferred dividends   385       385       385  
Net loss attributable to common shareholders $ (6,065 )   $ (2,848 )   $ (720 )
Basic loss per common share $ (1.48 )   $ (0.69 )   $ (0.17 )
Diluted loss per common share $ (1.48 )   $ (0.69 )   $ (0.17 )
                       

Loan Composition

(Dollars in thousands) 3/31/2026   12/31/2025   9/30/2025   6/30/2025   3/31/2025
  (Unaudited)       (Unaudited)   (Unaudited)   (Unaudited)
Real estate:                  
Residential $ 359,305     $ 365,427     $ 364,020     $ 356,559     $ 339,886  
Commercial   216,643       215,771       231,039       292,923       296,351  
Construction and land   36,732       48,397       43,700       53,187       46,740  
Commercial and industrial   171,666       181,566       194,654       223,239       234,384  
Commercial and industrial – PPP   6       6       13       191       457  
Consumer and other   82,269       86,441       90,946       93,333       93,889  
Loans held for investment, at amortized cost, gross   866,621       897,608       924,372       1,019,432       1,011,707  
Deferred loan costs, net   15,559       16,371       17,096       21,118       20,521  
Discount on government guaranteed loans   (6,007 )     (6,811 )     (7,506 )     (8,780 )     (8,727 )
Premium on loans purchased, net   2,446       2,650       2,941       3,342       3,415  
Loans held for investment, at amortized cost, net   878,619       909,818       936,903       1,035,112       1,026,916  
Government guaranteed loans held for investment, at fair value   51,807       54,076       61,780       90,687       57,901  
Total loans held for investment, net $ 930,426     $ 963,894     $ 998,683     $ 1,125,799     $ 1,084,817  
                                       

Nonperforming Assets (Unaudited)

(Dollars in thousands) 3/31/2026   12/31/2025   9/30/2025   6/30/2025   3/31/2025
Nonperforming loans (government guaranteed balances), at amortized cost, gross $ 5,580     $ 8,072     $ 8,865     $ 7,478     $ 9,728  
Nonperforming loans (unguaranteed balances), at amortized cost, gross   15,873       16,271       15,822       14,187       15,078  
Total nonperforming loans, at amortized cost, gross   21,453       24,343       24,687       21,665       24,806  
Nonperforming loans (government guaranteed balances), at fair value   208       83             502       507  
Nonperforming loans (unguaranteed balances), at fair value   1,230       1,453       1,385       1,430       1,419  
Total nonperforming loans, at fair value   1,438       1,536       1,385       1,932       1,926  
OREO   400       400       400       400       132  
Repossessed assets   583       263       32             36  
Total nonperforming assets, gross $ 23,874     $ 26,542     $ 26,504     $ 23,997     $ 26,900  
Nonperforming loans as a percentage of total loans held for investment(1)   2.44 %     2.68 %     2.63 %     2.09 %     2.42 %
Nonperforming loans (excluding government guaranteed balances) to total loans held for investment(1)   1.81 %     1.79 %     1.69 %     1.37 %     1.47 %
Nonperforming assets as a percentage of total assets   2.00 %     2.04 %     1.97 %     1.79 %     2.08 %
Nonperforming assets (excluding government guaranteed balances) to total assets   1.38 %     1.29 %     1.21 %     1.12 %     1.22 %
ACL to nonperforming loans(1)   96.17 %     90.35 %     99.18 %     78.66 %     66.57 %
ACL to nonperforming loans (excluding government guaranteed balances)(1)   129.98 %     135.18 %     154.75 %     120.12 %     109.52 %

(1) Excludes loans measured at fair value

Contact:
Scott J. McKim
Chief Financial Officer
727.521.7085
 



FactSet Recognized for Pioneering AI Advancements in Financial Technology

NORWALK, Conn., April 30, 2026 (GLOBE NEWSWIRE) — FactSet, a global financial digital platform and enterprise solutions provider, today announced a series of recent industry recognitions highlighting the impact of the firm’s continued investment in artificial intelligence and its application across financial data, analytics, and workflow solutions.

The awards reflect FactSet’s broader strategy to embed AI directly into the workflows of investment professionals, helping clients more efficiently access, analyze, and act on complex financial data.

“FactSet’s AI strategy is anchored in building open, flexible, and secure solutions that empower our clients to unlock actionable insights from trusted data—wherever they work,” said Kate Stepp, Chief AI Officer at FactSet. “We’re focused on accelerating the development and deployment of advanced AI capabilities, including autonomous agents, across our entire platform, collaborating closely with industry partners and clients to drive innovation and transform financial workflows for the future.”

Recent recognitions include:

FactSet remains at the forefront of AI innovation in the financial industry by fostering an open environment and collaborating with leading AI and data providers. Recent milestones include:

FactSet will highlight select AI-driven solutions and agentic innovations at its upcoming buy-side and wealth FOCUS user conference in Austin, TX, this May.

For more information on FactSet’s AI strategy and solutions, visit: https://www.factset.com/ai

About FactSet

FactSet (NYSE:FDS | NASDAQ:FDS) supercharges financial intelligence, offering enterprise data and information solutions that power our clients to maximize their potential. Our cutting-edge digital platform seamlessly integrates proprietary financial data, client datasets, third-party sources, and flexible technology to deliver tailored solutions across the buy-side, sell-side, wealth management, private equity, and corporate sectors. With over 47 years of expertise, a presence in 19 countries, and extensive multi-asset class coverage, we leverage advanced data connectivity alongside AI and next-generation tools to streamline workflows, drive productivity, and enable smarter, faster decision-making. Serving more than 9,000 global clients and over 241,000 individual users, FactSet is a member of the S&P 500 dedicated to innovation and long-term client success. Learn more at www.factset.com and follow us on X and LinkedIn.

FactSet

Investor Relations:
Kevin Toomey
+1.212.209.5259
[email protected]

Media Relations:
Vested
[email protected]